var title_f40_21_41296="Metagonimiasis adult worm";
var content_f40_21_41296=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metagonimiasis adult worm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 410px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Adult",
"    <em>",
"     M. yokogawai",
"    </em>",
"    . In this figure, the following structures are labeled: oral sucker (OS), pharynx (PH), intestine (IN), genitoacetabulum (GA), ovary (OV), the large, paired testes (TE), and eggs within the uterus (UT).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Metagonimiasis. Available at:",
"     <a href=\"file://dpd.cdc.gov/dpdx/html/Metagonimiasis.htm\" target=\"_blank\">",
"      file://dpd.cdc.gov/dpdx/html/Metagonimiasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41296=[""].join("\n");
var outline_f40_21_41296=null;
var title_f40_21_41297="Cystoscope";
var content_f40_21_41297=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Cystoscope",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A cystoscope with the parts fully assembled.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41297=[""].join("\n");
var outline_f40_21_41297=null;
var title_f40_21_41298="Contents: Office gynecology";
var content_f40_21_41298=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Office gynecology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Office gynecology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Breast disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/33/8728\">",
"           Breast pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/23/3449\">",
"           Nipple discharge",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/52/11081\">",
"           Overview of benign breast disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/32/35337\">",
"           Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/11/11449\">",
"           Postmenopausal hormone therapy and the risk of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/14/10474\">",
"           Screening for ovarian cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cervical and uterine disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/4/64\">",
"           Acute cervicitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/54/37736\">",
"           Cervical adenocarcinoma in situ",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/32/35337\">",
"           Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/25/9624\">",
"           Cervical cytology: Evaluation of atypical and malignant glandular cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/6/33895\">",
"           Cervical cytology: Evaluation of atypical squamous cells (ASC-US and ASC-H)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/54/28517\">",
"           Cervical cytology: Evaluation of high grade squamous intraepithelial lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/60/6086\">",
"           Cervical cytology: Evaluation of low grade squamous intraepithelial lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/21/31065\">",
"           Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/2/30762\">",
"           Cervical intraepithelial neoplasia: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/58/26535\">",
"           Classification and diagnosis of endometrial hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/0/26633\">",
"           Clinical manifestations and diagnosis of congenital anomalies of the uterus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/14/24808\">",
"           Colposcopy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/32/23048\">",
"           Congenital cervical anomalies and benign cervical lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/11/12473\">",
"           Diagnosis and management of congenital anomalies of the vagina",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/38/22121\">",
"           Differentiating uterine leiomyomas (fibroids) from uterine sarcomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/10/7336\">",
"           Endometrial polyps",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/1/17431\">",
"           Endometritis unrelated to pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/17/6426\">",
"           Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/35/25143\">",
"           Histology and pathogenesis of uterine leiomyomas (fibroids)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/3/37943\">",
"           Management of endometrial hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/14/18666\">",
"           Overview of treatment of uterine leiomyomas (fibroids)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/11/39097\">",
"           Postpartum endometritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/60/39879\">",
"           Primary dysmenorrhea in adult women: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/24/16775\">",
"           Prolapsed uterine leiomyoma (fibroid)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/60/30662\">",
"           Reproductive issues in women with uterine leiomyomas (fibroids)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/4/36934\">",
"           Screening for cervical cancer in HIV infected women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/21/29014\">",
"           Surgical management of congenital uterine anomalies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/43/42681\">",
"           The gynecologic history and pelvic examination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/36/28233\">",
"           Treatment of primary dysmenorrhea in adult women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/35/27191\">",
"           Uterine adenomyosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/60/22473\">",
"           Uterine leiomyoma (fibroid) embolization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/3/17465\">",
"           Variants of uterine leiomyomas (fibroids)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Contraception",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/38/20070\">",
"           Barrier contraception: Diaphragm",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/8/4233\">",
"           Contraception counseling for obese women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/8/26759\">",
"           Contraception for women with inherited thrombophilias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/13/42201\">",
"           Contraception: Overview of issues specific to adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/54/33640\">",
"           Contraceptive vaginal ring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/0/32777\">",
"           Counseling women considering combined hormonal contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/45/34522\">",
"           Depot medroxyprogesterone acetate for contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/5/31833\">",
"           Emergency contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/27/3512\">",
"           Etonogestrel contraceptive implant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/13/5334\">",
"           Female condoms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/58/37800\">",
"           Fertility awareness-based methods of pregnancy prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/29/34265\">",
"           Insertion and removal of an intrauterine contraceptive device",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/62/30696\">",
"           Male condoms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/27/19898\">",
"           Management of problems related to intrauterine contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/10/22698\">",
"           Management of unscheduled bleeding in women using contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/38/33386\">",
"           Mifepristone for the medical termination of pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/24/39306\">",
"           Overview of contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/19/32058\">",
"           Overview of intrauterine contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/5/18522\">",
"           Overview of the use of estrogen-progestin contraceptives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/52/9031\">",
"           Progestin-only pills (minipills) for contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/7/39034\">",
"           Risks and side effects associated with estrogen-progestin contraceptives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/10/41127\">",
"           Transdermal contraceptive patch",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Early pregnancy complications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/9/1178\">",
"           Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/6/8298\">",
"           Definition and etiology of recurrent pregnancy loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/3/26679\">",
"           Evaluation of couples with recurrent pregnancy loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/15/21752\">",
"           Incidence, risk factors, and pathology of ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/5/37976\">",
"           Management of couples with recurrent pregnancy loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27417\">",
"           Methotrexate treatment of tubal and interstitial ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/29/39384\">",
"           Retained products of conception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/49/2841\">",
"           Spontaneous abortion: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/23/19834\">",
"           Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/53/5976\">",
"           Surgical treatment of ectopic pregnancy and prognosis for subsequent fertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/24/34184\">",
"           Ultrasonography of pregnancy of unknown location",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ectopic pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/4/16457\">",
"           Abdominal pregnancy, cesarean scar pregnancy, and heterotopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/9/1178\">",
"           Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/60/21444\">",
"           Expectant management of ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/15/21752\">",
"           Incidence, risk factors, and pathology of ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27417\">",
"           Methotrexate treatment of tubal and interstitial ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/53/5976\">",
"           Surgical treatment of ectopic pregnancy and prognosis for subsequent fertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/24/34184\">",
"           Ultrasonography of pregnancy of unknown location",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/1/24601\">",
"           Approach to the patient with an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/1/43032\">",
"           Approach to the woman with sexual pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/26/41384\">",
"           Causes of chronic pelvic pain in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/28/40389\">",
"           Clinical manifestations and diagnosis of myofascial pelvic pain syndrome in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/54/24420\">",
"           Culdocentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/37/23128\">",
"           Differential diagnosis of sexual pain in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/57/19352\">",
"           Differential diagnosis of the adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/38/35433\">",
"           Estrogen-associated migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/52/10054\">",
"           Evaluating diagnostic tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/44/17095\">",
"           Evaluation of acute pelvic pain in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/7/31864\">",
"           Evaluation of chronic pelvic pain in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/37/24150\">",
"           Hysterosalpingography",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/15/21752\">",
"           Incidence, risk factors, and pathology of ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/44/30408\">",
"           Interventional radiology in management of gynecological disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/11/30905\">",
"           Management of an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/22/43369\">",
"           Management of interstitial cystitis/bladder pain syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/33/25113\">",
"           Medical care of women who have sex with women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/40/4746\">",
"           Occupational and environmental risks to reproduction in females",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/13/11482\">",
"           Optimizing natural fertility in couples planning pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/15/3322\">",
"           Outcome and follow-up of diethylstilbestrol (DES) exposed individuals",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/8/8330\">",
"           Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/22/33127\">",
"           Pelvic floor physical therapy for management of myofascial pelvic pain syndrome in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/55/40823\">",
"           Saline infusion sonohysterography",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/42/25258\">",
"           Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/10/34985\">",
"           Sexual dysfunction in women: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/43/42681\">",
"           The gynecologic history and pelvic examination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/18/28969\">",
"           Treatment of chronic pelvic pain in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/11/5305\">",
"           Treatment of myofascial pelvic pain syndrome in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/61/30681\">",
"           Vulvovaginal varicosities and pelvic congestion syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genital tract bleeding",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/41/20122\">",
"           Chronic menorrhagia or anovulatory uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/2/44071\">",
"           Evaluation and management of lower genital tract trauma in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/53/38744\">",
"           Evaluation of the endometrium for malignant or premalignant disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/26/37285\">",
"           Heavy or irregular uterine bleeding during chemotherapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/47/3832\">",
"           Hormonal contraception for suppression of menstruation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/25/20887\">",
"           Initial approach to the premenopausal woman with abnormal uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/2/11305\">",
"           Managing an episode of severe or prolonged uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/18/35113\">",
"           Overview of causes of genital tract bleeding in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/55/8054\">",
"           Postcoital bleeding in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/41/2711\">",
"           Postmenopausal uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/24/23944\">",
"           Terminology and evaluation of abnormal uterine bleeding in premenopausal women",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infertility",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/18/3367\">",
"           Causes of female infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/61/40921\">",
"           Evaluation of female infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/37/24150\">",
"           Hysterosalpingography",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/56/17287\">",
"           Overview of infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/5/14425\">",
"           Overview of treatment of female infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/52/22343\">",
"           Psychological stress and infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/57/25496\">",
"           Unexplained infertility",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Inflammation and infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/49/36633\">",
"           Approach to women with symptoms of vaginitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/56/30602\">",
"           Bacterial vaginosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/1/15386\">",
"           Candida vulvovaginitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/0/1032\">",
"           Clinical features and diagnosis of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/63/37876\">",
"           Desquamative inflammatory vaginitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/61/36823\">",
"           Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/58/934\">",
"           Long-term complications of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/34/43560\">",
"           Management and complications of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/45/11992\">",
"           Pathogenesis of and risk factors for pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/11/39097\">",
"           Postpartum endometritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/63/35832\">",
"           Treatment of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/34/27178\">",
"           Treatment of vulvar and vaginal warts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/53/1881\">",
"           Trichomonas vaginalis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/22/1380\">",
"           Urethral caruncle",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menopause",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/45/20184\">",
"           Androgen production and therapy in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/45/44761\">",
"           Clinical manifestations and diagnosis of menopause",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/34/40486\">",
"           Continuous postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/63/41975\">",
"           Estrogen and cognitive function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/38/35433\">",
"           Estrogen-associated migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/53/25434\">",
"           Menopausal hot flashes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/22/15720\">",
"           Ovarian development and failure (menopause) in normal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/36/29258\">",
"           Postmenopausal hormone therapy and cardiovascular risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/11/11449\">",
"           Postmenopausal hormone therapy and the risk of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/41/2711\">",
"           Postmenopausal uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/53/16218\">",
"           Preparations for postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/42/40615\">",
"           Treatment of menopausal symptoms with hormone therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menstrual function",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/38/35433\">",
"           Estrogen-associated migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/6/26724\">",
"           Evaluation of the menstrual cycle and timing of ovulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/47/3832\">",
"           Hormonal contraception for suppression of menstruation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/18/35113\">",
"           Overview of causes of genital tract bleeding in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27685\">",
"           Physiology of the normal menstrual cycle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/62/21481\">",
"           Premature adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/24/23944\">",
"           Terminology and evaluation of abnormal uterine bleeding in premenopausal women",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pelvic relaxation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/33/40473\">",
"           An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/37/43607\">",
"           Pelvic organ prolapse in women: Obliterative procedures (colpocleisis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/4/35914\">",
"           Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy termination",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/38/33386\">",
"           Mifepristone for the medical termination of pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/42/28330\">",
"           Misoprostol as a single agent for medical termination of pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/14/41191\">",
"           Unsafe abortion",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Premenstrual syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/52/39751\">",
"           Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/16/28935\">",
"           Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/10/3241\">",
"           Treatment of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tuboovarian disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/57/19352\">",
"           Differential diagnosis of the adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/23/23927\">",
"           Early detection of epithelial ovarian cancer: Role of symptom recognition",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/61/36823\">",
"           Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/40/9863\">",
"           Evaluation and management of ruptured ovarian cyst",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/34/43560\">",
"           Management and complications of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/14/10474\">",
"           Screening for ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/40/34440\">",
"           Sonographic differentiation of benign versus malignant adnexal masses",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urinary incontinence",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/14/29929\">",
"           Clinical presentation and diagnosis of urinary incontinence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/1/7192\">",
"           Epidemiology, risk factors, and pathogenesis of urinary incontinence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/4/32842\">",
"           Treatment of urinary incontinence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/23/32120\">",
"           Urodynamic evaluation of women with incontinence",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vulvovaginal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/49/36633\">",
"           Approach to women with symptoms of vaginitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/56/30602\">",
"           Bacterial vaginosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/1/15386\">",
"           Candida vulvovaginitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/6/8295\">",
"           Clinical manifestations and diagnosis of generalized vulvodynia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/46/37609\">",
"           Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/54/8039\">",
"           Clinical manifestations and diagnosis of vaginal atrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/13/5336\">",
"           Dermatitis of the vulva",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/63/37876\">",
"           Desquamative inflammatory vaginitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/11/12473\">",
"           Diagnosis and management of congenital anomalies of the vagina",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/30/37349\">",
"           Diagnostic evaluation of vulvar lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/8/20618\">",
"           Differential diagnosis of vulvar lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/54/22375\">",
"           Disorders of Bartholin gland",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/10/37028\">",
"           Labia minora hypertrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/7/6265\">",
"           Pathogenesis, clinical features, and diagnosis of hidradenitis suppurativa",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/44/24266\">",
"           Treatment of hidradenitis suppurativa",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/50/6954\">",
"           Treatment of vaginal atrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/55/16249\">",
"           Treatment of vulvodynia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/53/1881\">",
"           Trichomonas vaginalis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/5/36952\">",
"           Vulvar lichen planus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/45/6874\">",
"           Vulvar lichen sclerosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/61/30681\">",
"           Vulvovaginal varicosities and pelvic congestion syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/63/28659\">",
"           Word catheter placement for treatment of Bartholin cysts and abscesses",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-E579B9E1B6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f40_21_41298=[""].join("\n");
var outline_f40_21_41298=null;
var title_f40_21_41299="Crohns vulva2";
var content_f40_21_41299=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69563&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69563&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar involvement in Crohn's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 330px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41299=[""].join("\n");
var outline_f40_21_41299=null;
var title_f40_21_41300="Haemophilus influenzae type b-meningococcal serogroups CY combination vaccine: Drug information";
var content_f40_21_41300=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Haemophilus influenzae type b-meningococcal serogroups CY combination vaccine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/29/40404?source=see_link\">",
"    see \"Haemophilus influenzae type b-meningococcal serogroups CY combination vaccine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F14470407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine, Inactivated (Bacterial)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F14944459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/29/40404?source=see_link\">",
"      see \"Haemophilus influenzae type b-meningococcal serogroups CY combination vaccine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Primary immunization:",
"     </b>",
"     Children 6 weeks to 18 months: I.M.: 0.5 mL/dose given as a four-dose series at 2, 4, 6, and 12-15 months of age. The first dose may be given as early as 6 weeks of age and the fourth dose may be given as late as 18 months of age.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     The ACIP recommends vaccination only for infants 6 weeks to 18 months of age who are at an increased risk for meningococcal disease. If an infant at increased risk is behind on Hib vaccine doses, Hib-MenCY-TT may be used to catch up using the current Hib schedule. If the first dose of Hib-MenCY-TT is given &ge;12 months of age, two doses should be given 8 weeks apart. If infants have/will receive a different Hib vaccine, a two-dose series of a quadrivalent meningococcal vaccine is recommended (Menactra&reg; for ages 9-23 months; Menactra&reg; or Menveo&reg; for ages &gt;23 months) (CDC, 2013).",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16317905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16317906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F14944375\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F14471244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     MenHibrix&reg;: FDA approved June 2012; availability expected April 2013. Consult prescribing information for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F14944460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer by I.M. injection in the anterolateral aspect of the thigh in children &lt;1 year of age or the deltoid muscle in children &gt;1 year of age. Do not administer I.V., SubQ, or intradermally.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Do not coadminister with other Hib-containing vaccines (CDC, 2013).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     For patients at risk of hemorrhage following intramuscular injection, the ACIP recommends &ldquo;it should be administered intramuscularly if, in the opinion of the physician familiar with the patient's bleeding risk, the vaccine can be administered by this route with reasonable safety. If the patient receives antihemophilia or other similar therapy, intramuscular vaccination can be scheduled shortly after such therapy is administered. A fine needle (23 gauge or smaller) can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least 2 minutes. The patient should be instructed concerning the risk of hematoma from the injection.&rdquo; Patients on anticoagulant therapy should be considered to have the same bleeding risks and treated as those with clotting factor disorders (CDC, 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Simultaneous administration of vaccines helps ensure the patients will be fully vaccinated by the appropriate age. Simultaneous administration of vaccines is defined as administering &gt;1 vaccine on the same day at different anatomic sites. The use of licensed combination vaccines is generally preferred over separate injections of the equivalent components. Separate vaccines should not be combined in the same syringe unless indicated by product specific labeling. Separate needles and syringes should be used for each injection. The ACIP prefers each dose of a specific vaccine in a series come from the same manufacturer when possible. Adolescents and adults should be vaccinated while seated or lying down. In general, preterm infants should be vaccinated at the same chronological age as full-term infants (CDC, 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Antipyretics have not been shown to prevent febrile seizures. Antipyretics may be used to treat fever or discomfort following vaccination (CDC, 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; the clinical significance of this reduction in immune response has not been established (Prymula, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F14470409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To provide active immunity to prevent invasive disease caused by meningococcal serogroups C and Y and",
"     <i>",
"      Haemophilus influenzae",
"     </i>",
"     type b",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     The Advisory Committee on Immunization Practices (ACIP) recommends vaccination only for infants 6 weeks to 18 months of age who are at increased risk for meningococcal disease, including:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     - 	Infants with persistent complement pathway deficiencies",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     - Infants with anatomic or functional asplenia, including sickle cell disease",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     - 	Infants in communities with serogroups C and Y meningococcal disease outbreaks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     The ACIP does not recommend routine vaccination for infants not at increased risk for meningococcal disease. In addition, infants traveling to certain areas (eg, meningitis belt of sub-Saharan Africa) will require a meningococcal vaccine with serogroups A and W",
"     <sub>",
"      135",
"     </sub>",
"     ; vaccination with Hib-MenCY-TT will not be adequate (CDC, 2013).",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F14944374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       MenHibrix&reg; (Meningococcal Polysaccharide (Groups C and Y) and",
"       <i>",
"        Haemophilus",
"       </i>",
"       b Tetanus Toxoid Conjugate Vaccine) may be confused with Hiberix&reg; (",
"       <i>",
"        Haemophilus",
"       </i>",
"       b Conjugate Vaccine)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F14944408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"     In Canada, adverse reactions may be reported to local provincial/territorial health agencies or to the Vaccine Safety Section at Public Health Agency of Canada (1-866-844-0018).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:0em;\">",
"     Central nervous system: Irritability (62% to 71%), drowsiness (49% to 63%), fever &ge;100.4&deg;F/38&deg;C (11% to 26%)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:0em;\">",
"     Gastrointestinal: Appetite decreased (30% to 34%)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:0em;\">",
"     Local: Injection site reactions: Pain (41% to 46%), redness (21% to 36%), swelling (15% to 25%)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;\">",
"     Postmarketing and/or case reports: Allergic reactions, anaphylactic/anaphylactoid reactions, angioedema, apnea, hypotonic-hyporesponsive episode, injection site induration, rash, somnolence, seizures (with or without fever), swelling of vaccinated limb (extensive), syncope, urticaria, vasovagal response",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F14944378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Severe allergic reaction to any meningococcal,",
"     <i>",
"      H. influenza",
"     </i>",
"     type B, or tetanus toxoid-containing vaccine, or any component of the vaccine",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F14944389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Immediate treatment (including epinephrine 1:1000) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Apnea: Apnea has been reported following I.M. vaccine administration in premature infants; consider risk versus benefit in infants born prematurely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Syncope: Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Acute illness: The decision to administer or delay vaccination because of current or recent febrile illness depends on the severity of symptoms and the etiology of the disease. Immunization should be delayed during the course of an acute febrile illness.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Bleeding disorders: Use with caution in patients with a history of bleeding disorders (including thrombocytopenia) and/or patients on anticoagulant therapy; bleeding/hematoma may occur from I.M. administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Guillain-Barr&eacute; syndrome (GBS): Use with caution in patients with history of GBS; carefully consider risks and benefits to vaccination in patients known to have experienced GBS within 6 weeks following previous influenza vaccination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Vaccines: In order to maximize vaccination rates, the ACIP recommends simultaneous administration of all age-appropriate vaccines (live or inactivated) for which a person is eligible at a single clinic visit, unless contraindications exist. The use of combination vaccines is generally preferred over separate injections, taking into consideration provider assessment, patient preference, and adverse events. When using combination vaccines, the minimum age for administration is the oldest minimum age for any individual component; the minimum interval between dosing is the greatest minimum interval between any individual component.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Altered immunocompetence: Has not been evaluated for use in immunosuppressed children. In general, severely immunocompromised patients (eg, patients receiving chemo/radiation therapy or other immunosuppressive therapy [including high-dose corticosteroids]) may have a reduced response to vaccination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Tetanus vaccine: Not a substitute for routine tetanus immunization.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and is improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F14975263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F14975261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F14944376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14944377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F14944471\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;margin-top:0em;display:inline\">",
"     Monitor for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F14944420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Provides active immunity against meningococcal disease via the formation of bactericidal antibodies directed toward the polysaccharide capsular components of",
"     <i>",
"      Neisseria meningitidis",
"     </i>",
"     serogroups C and Y; stimulates production of anticapsular antibodies and to",
"     <i>",
"      Haemophilus influenzae",
"     </i>",
"     type b",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F14944443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset: Antibody response to the components of the vaccine occurs in &ge;95% of children following the third dose and &ge;98% following the fourth dose.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2013, 62:52-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/21/41300/abstract-text/23344698/pubmed\" id=\"23344698\" target=\"_blank\">",
"        23344698",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/21/41300/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, &ldquo;Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/21/41300/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 85641 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-01FC61200C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41300=[""].join("\n");
var outline_f40_21_41300=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14470407\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944459\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317905\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317906\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944375\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471244\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944460\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14470409\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944374\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944408\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944378\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944389\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14975263\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14975261\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944376\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944377\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944471\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944420\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14944443\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/85641\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/85641|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/29/40404?source=related_link\">",
"      Haemophilus influenzae type b-meningococcal serogroups CY combination vaccine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_21_41301="Paraneoplastic pemphigus TEN-like";
var content_f40_21_41301=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread skin sloughing and erosions in paraneoplastic pemphigus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41301=[""].join("\n");
var outline_f40_21_41301=null;
var title_f40_21_41302="Molecular intrinsic subtypes of breast cancer";
var content_f40_21_41302=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Molecular intrinsic subtypes of breast cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41302/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41302/contributors\">",
"     Lisa A Carey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41302/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41302/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41302/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41302/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/21/41302/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast cancer is a heterogeneous and phenotypically diverse disease. It is composed of several biologic subtypes that have distinct behaviors and responses to therapy. This heterogeneity was first noted over 100 years ago with the identification that simple removal of the ovaries was therapeutic in some breast cancer patients, but not others. The molecular characterization (profiling) of breast cancer has significantly advanced since the turn of the millennium due to the development of sophisticated technologies, such as gene expression arrays, which permit simultaneous measurement of thousands of genes to create a molecular portrait of the tumor.",
"   </p>",
"   <p>",
"    The breast cancer intrinsic subtypes that have been identified because of differences in gene expression patterns will be reviewed here. The use of gene expression profiling to develop prognosis signatures and other prognostic and predictive markers used for breast cancer are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/22/6503?source=see_link\">",
"       \"Prognostic molecular profiles of breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/28/43465?source=see_link\">",
"       \"Measurement of prognostic factors in breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link\">",
"       \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MOLECULAR PROFILING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular profiling, based upon variations in gene expression, is employed in two different ways: to characterize breast cancers beyond traditional histopathologic criteria (ie, grade, histology, and immunohistochemical analysis of hormone receptors and human epidermal growth factor receptor-2 [HER2] overexpression) and as a predictor of response to therapy and clinical outcome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/22/6503?source=see_link\">",
"     \"Prognostic molecular profiles of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cellular and molecular heterogeneity of breast cancer and the large number of genes involved in controlling cell growth, death, and differentiation emphasize the importance of studying multiple genetic alterations in concert. Gene expression profiling allows the simultaneous measurement of the activity (expression) of thousands of genes in a breast cancer cell. Future applications of high-throughput examinations will doubtless take the same approach to proteins (proteomics), genome-wide germline variability (single nucleotide polymorphisms), or cellular metabolism (metabolomics). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link\">",
"     \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Technical aspects and limitations of profiling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gene expression arrays measure the level of expression of a group of genes in a semiquantitative manner by determining the level of messenger RNA (mRNA) in tumor compared to a reference sample. In general, a tumor (typically using frozen tissue) is processed and then RNA (or cDNA) is labeled with a fluorescent probe and applied to an array, where it hybridizes and binds to the specific gene probes on the array. Convention dictates that in a two-color array, the tumor is labeled red and the reference sample green (",
"    <a class=\"graphic graphic_figure graphicRef82165 \" href=\"mobipreview.htm?14/39/14967\">",
"     figure 1",
"    </a>",
"    ). The strength of the red:green ratio reflects the relative expression level for each gene. Computers are used to look for patterns of expression in thousands of genes simultaneously. Once a profile is identified, a far more limited number of genes (usually 10 to 100) may be used to categorize a tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Unsupervised and supervised analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two main types of molecular profiling analyses relevant today: unsupervised and supervised analyses. Unsupervised analysis (or clustering) permits examination of gene expression patterns heedless of clinical endpoints and reflects inherent biologic differences. Supervised analyses are those in which the gene sets are designed to differentiate tumors by a defined clinical endpoint. The prognostic molecular profiles (prognosis signatures) used to predict response to treatment and clinical outcomes are examples of supervised analyses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/22/6503?source=see_link\">",
"     \"Prognostic molecular profiles of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A third method, the semisupervised analysis, takes pre-selected genes chosen because of their association with a clinical variable(s) of interest and conducts an unsupervised analysis of the resulting gene expression data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/1\">",
"     1",
"    </a>",
"    ]. The characterization of breast cancer intrinsic subtypes is a result of such a semisupervised analysis. This is discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     BREAST CANCER INTRINSIC SUBTYPES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gene expression studies have identified several distinct breast cancer subtypes that differ markedly in prognosis and in the therapeutic targets they express [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/2-10\">",
"     2-10",
"    </a>",
"    ]. The list of genes that differentiates these subtypes is called the",
"    <a class=\"external\" href=\"file://www.pnas.org/content/98/19/10869/F1.expansion.html\">",
"     intrinsic list",
"    </a>",
"    and is made up of several clusters of genes relating to estrogen receptor (ER) expression (the luminal cluster), human epidermal growth factor 2 (HER2) expression, proliferation, and a unique cluster of genes called the basal cluster. Others are being identified as investigators continue to study the genomic data derived from breast cancer specimens.",
"   </p>",
"   <p>",
"    The intrinsic subtypes segregate into two groups that correspond to expression of hormone receptor-related genes. This segregation is consistent with both the literature and clinical experience that show ER-positive and ER-negative cancers define biologically distinct phenotypes that may derive from different progenitor cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/6\">",
"     6",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Luminal subtypes &mdash; Luminal A and luminal B, which express genes associated with luminal epithelial cells of normal breast tissue and overlap with ER-positive breast cancers defined by clinical assays. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Luminal subtypes'",
"      </a>",
"      below.) .",
"     </li>",
"     <li>",
"      HER2-enriched subtype &mdash; The HER2-enriched subtype comprises the majority of clinically HER2-positive breast cancers. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'HER2-enriched'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      ER-negative subtypes &mdash; There are several ER-negative subtypes characterized by low expression of hormone receptor-related genes. These include the basal-like, claudin-low, interferon-rich, androgen receptor, and normal-like subtypes. (See",
"      <a class=\"local\" href=\"#H1133231165\">",
"       'ER-negative subtypes'",
"      </a>",
"      below.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further discussion of these molecular intrinsic breast cancer subtypes is reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Luminal subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The name \"luminal\" derives from similarity in gene expression between these tumors and the luminal epithelium of the breast; they typically express luminal cytokeratins 8 and 18. These are the most common subtypes, make up the majority of ER-positive breast cancer, and are characterized by expression of ER, PR, and other genes associated with ER activation. Despite comprising the majority of ER-positive breast cancers, the luminal A and luminal B subtypes have some important molecular and prognostic distinctions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/22/6503?source=see_link\">",
"     \"Prognostic molecular profiles of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Luminal A tumors, which probably make up about 40 percent of all breast cancers, usually have high expression of ER-related genes, low expression of the HER2 cluster of genes, and low expression of proliferation-related genes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. Luminal A tumors are the most common subtype and in general, carry the best prognosis of all breast cancer subtypes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/6-8,13,14\">",
"       6-8,13,14",
"      </a>",
"      ]. Despite this, most breast cancer deaths are from ER-positive, HER2-negative disease and racial disparity in outcome is particularly found in this subset [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The less common (about 20 percent) luminal B tumors have relatively lower (although still present) expression of ER-related genes, variable expression of the HER2 cluster, and higher expression of the proliferation cluster. Luminal B tumors carry a worse prognosis than luminal A tumors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/14\">",
"       14",
"      </a>",
"      ]. Most luminal B cancers have high recurrence scores as assessed by the 12-gene recurrence score assay and poor 70-gene prognostic signatures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link&amp;anchor=H2#H2\">",
"       \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\", section on 'GEP and DNA microarray analysis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     HER2-enriched",
"    </span>",
"    &nbsp;&mdash;&nbsp;The HER2-enriched subtype (previously the",
"    <span class=\"nowrap\">",
"     HER2-positive/ER-negative",
"    </span>",
"    subtype) makes up about 10 to 15 percent of breast cancers and is characterized by high expression of the HER2 and proliferation gene clusters, and low expression of the luminal and basal clusters. For this reason, these tumors are most often negative for ER and PR, and positive for HER2. However, the HER2-enriched subtype is not synonymous with clinically HER2-positive breast cancer. While half of clinical HER2-positive breast cancers are HER2-enriched, the other half can include any molecular subtype but is mostly made up of HER2-positive luminal subtypes. About 30 percent of HER2-enriched tumors are clinically HER2-negative. While the impact of HER2-targeting in these tumors is being studied, it is possible that at least some represent HER2 mutations or other events in the HER2 signaling pathway producing a similar expression phenotype without HER2 amplification or protein overexpression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1133231165\">",
"    <span class=\"h2\">",
"     ER-negative subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ER-negative subtypes include basal-like, claudin-low, interferon-rich, androgen-receptor driven, and a normal-like subtype. Most of these fall under the category of triple-negative breast cancers because they are also progesterone receptor (PR) negative and HER2 negative. These subtypes are reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Basal-like",
"    </span>",
"    &nbsp;&mdash;&nbsp;The basal-like subtype, so called because of some similarity in gene expression to that of the basal epithelial cells of normal breast tissue, makes up about 15 to 20 percent of breast cancers. It is characterized by low expression of the luminal and HER2 gene clusters. For this reason, these tumors are typically ER-negative, progesterone receptor negative (PR-negative), and HER2-negative on clinical assays, which has prompted the nickname \"triple-negative breast cancers\" to describe them. However, while most triple-negative breast cancers are basal-like, and most basal-like tumors are triple-negative, there is significant discordance (up to 30 percent) between these two classification methods that must be kept in mind when evaluating studies focused upon basal-like breast cancer. Triple-negative breast cancer is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/40/34441?source=see_link\">",
"     \"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Basal-like tumors have high expression of the proliferation cluster of genes, are virtually always high grade, and contain widespread genomic instability even early in the disease. They are generally typified by genes relating to proliferation and loss of cell cycle control. Some basal-like subsets appear to have elevated DNA damage response pathway concomitant with proliferation gene expression, while others have strong expression of growth factor receptor pathway genes (EGFR, IGF1R, Wnt, and MET) and genes related to cellular metabolism. They also have high expression of a unique cluster of genes called the basal cluster, which includes basal epithelial cytokeratins 5, 14, and 17.",
"   </p>",
"   <p>",
"    Basal-like breast cancer has unique risk factors. Among the most intriguing is the strong association with cancers arising in women born with a mutation in the breast cancer gene 1, early onset (BRCA1) gene, in whom over 80 percent are basal-like [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/7,16-18\">",
"     7,16-18",
"    </a>",
"    ]. Even so, most basal-like breast cancers are sporadic, and the BRCA1 gene and protein appear intact in these tumors. A commonly held, but unproven, assumption is that the BRCA1 pathway is abnormal in sporadic basal-like breast cancer, which may have therapeutic implications since this pathway is important in DNA repair. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/40/34441?source=see_link&amp;anchor=H624350409#H624350409\">",
"     \"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer\", section on 'BRCAness'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another notable association is between the basal-like subtype and race and age. Population-based studies suggest that the basal-like subtype is overrepresented in breast cancer developing during the premenopausal years and in African-American women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/19-24\">",
"     19-24",
"    </a>",
"    ]. For this reason, it is particularly prevalent among young African-American women. Basal-like breast cancer carries a poor prognosis; it is possible that this prevalence may contribute in part to the worse outcomes experienced by African-American women with breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/14\">",
"     14",
"    </a>",
"    ]. Fortunately, studies suggest that basal-like breast cancers are sensitive to modern chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. However, the absence of targeted therapy of known effectiveness in this subtype remains a real obstacle to improving outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H366660450\">",
"    <span class=\"h3\">",
"     Claudin-low",
"    </span>",
"    &nbsp;&mdash;&nbsp;The claudin-low subgroup comprises 5 to 10 percent of breast cancers and has triple-negative breast cancer or basal-like phenotypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/2\">",
"     2",
"    </a>",
"    ]. Although uncommon, it is interesting because of its expression of epithelial-mesenchymal transition genes and characteristics reminiscent of stem cells. It is characterized by low to absent expression of epithelial cell-cell adhesion genes (claudin 3, 4 and 7, and E-cadherin), differentiated luminal cell surface markers (EpCAM and MUC1), and enrichment for epithelial-to-mesenchymal transition markers, immune response genes, and cancer stem cell-like features",
"    <span class=\"nowrap\">",
"     (CD44+/CD24-",
"    </span>",
"    and high ALDH1A1). In contrast to basal-like breast cancers, claudin-low tumors appear to be slower growing and, with features of mesenchymal and mammary stem cells, may be of different oncogenic origin. Metaplastic and medullary breast cancers often overlap with the claudin-low subtype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1133231208\">",
"    <span class=\"h3\">",
"     Interferon-rich/immunomodulatory",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     interferon-rich/immunomodulatory",
"    </span>",
"    subtype is a triple-negative breast cancer subtype that appears to carry a better prognosis. It is characterized by high gene expression of complement and immune response pathway genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1133231218\">",
"    <span class=\"h3\">",
"     Androgen receptor-driven",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen receptor-driven triple-negative breast cancers have high expression of hormonally mediated pathways in spite of low estrogen receptor expression, with AR protein detectable by immunostains. Several groups have found this subset in triple-negative breast cancer, which is a small minority but given the targetability and therapeutic implications of AR expression, clinical trials of AR-targeted agents are underway in selected tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1133231226\">",
"    <span class=\"h3\">",
"     Normal-like",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal-like subtype was one of the initial subtypes identified by gene expression array and consistently appears in breast cancer clusters. It is, as expected, typified by similar gene expression pattern as normal breast, and remains enigmatic as to whether it represents a separate subtype or a technical artifact introduced by low tumor cell composition of the sampled specimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intrinsic subtypes were developed to identify relevant biology, not for prognostication; however, in multiple independent datasets, these subtypes correlate with prognosis. In general, patients with the luminal A subtype have the best prognosis; patients with the other major hormone receptor-positive subtype, luminal B, suffer a comparatively worse outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/20\">",
"     20",
"    </a>",
"    ]. Both the basal-like and HER2-enriched subtypes have the worst survival, at least until recently; the era of HER2-targeting has altered the outcome for the HER2-enriched subtype and HER2-positive luminal cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11384?source=see_link\">",
"     \"Adjuvant medical therapy for HER2-positive breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/43/22202?source=see_link&amp;anchor=H111523989#H111523989\">",
"     \"Systemic treatment for metastatic breast cancer: Molecular targeted therapy\", section on 'HER2-directed therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An example of the prognostic impact of intrinsic subtype was presented at the 2011 San Antonio Breast Cancer Symposium by the Translational Arimidex versus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     Tamoxifen",
"    </a>",
"    Alone or in Combination (TransATAC) investigators [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/28\">",
"     28",
"    </a>",
"    ]. Approximately 1000 tumor specimens from patients participating on the ATAC study were analyzed using PAM50 to define Luminal A versus Luminal B breast cancer subtype. Compared to patients with Luminal A tumors, patients with luminal B tumors had the following results at 10 years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among node-negative patients &mdash; A significant risk of disease progression or death (hazard ratio, 4.78, 95% CI 2.97-7.70)",
"     </li>",
"     <li>",
"      Among node-positive patients &mdash; A significant risk of disease progression or death among women with up to three nodes involved (HR 2.20, 95% CI 1.10-3.61) and those with four or more nodes (HR 3.40, 95% CI 1.60-7.22)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to keep in mind that while breast cancer subtype appears to be associated with prognosis, subtype does not exclusively define prognosis. There is racial variation in intrinsic subtype, and racial disparities in breast cancer outcome persist despite stratification by subtype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1133231104\">",
"    <span class=\"h1\">",
"     CLINICAL CHARACTERIZATION OF MOLECULAR SUBTYPES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite our identification of breast cancer intrinsic subtypes and their association with outcomes, there is no clearly established method to classify breast cancers in clinical situations. The studies described above that defined the intrinsic subtypes utilized gene expression data from banked frozen tissue and cannot be adapted with good reproducibility using formalin-fixed paraffin-embedded tissue. While some experts have proposed immunohistochemical surrogates for the intrinsic subtypes, these have not been validated. The simplest schema using clinical assays for ER, progesterone receptor (PR), and HER2 misclassifies a significant proportion of tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/20\">",
"     20",
"    </a>",
"    ]. A recently developed assay, called the PAM50, has been validated in several datasets for clinical use. A commercial assay modified from the PAM50 assay, called the Risk of Recurrence Score, was used in the TransATAC study described above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/28\">",
"     28",
"    </a>",
"    ] and was recently approved for prognostication in hormone receptor-positive, HER2-negative breast cancer in Europe. The PAM50 can be performed on fixed tissue and uses a reverse transcription-polymerase chain reaction (RT-PCR) based method to characterize subtype based on a 50 gene set [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41302/abstract/19,28\">",
"     19,28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Prognosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular profiling, based upon variations in gene expression, has identified several distinct breast cancer subtypes, named the breast cancer intrinsic subtypes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Luminal A and B are the most common subtypes and make up the majority of estrogen receptor (ER)-positive breast cancers. Luminal A tumors carry the best prognosis of all of the subtypes. Luminal B tumors have a lower expression of ER-related genes, variable expression of the human epidermal growth factor receptor-2 (HER2) cluster, and higher expression of the proliferation cluster. Consequently, luminal B tumors have a poorer prognosis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Luminal subtypes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HER2-enriched",
"      <span class=\"nowrap\">",
"       (HER2-positive/ER-negative)",
"      </span>",
"      subtype cancers are often negative for ER and progesterone receptor (PR), and positive for HER2. The poor prognosis associated with these tumors has been undoubtedly altered by HER2-directed therapies. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'HER2-enriched'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Basal-like tumors are typically ER-negative, PR-negative, and HER2-negative on clinical assays, which has prompted the nickname \"triple-negative\" to describe them. They have a strong association with cancers arising in breast cancer gene 1, early onset (BRCA1) mutation carriers and are overrepresented in breast cancer developing during the premenopausal years and in African-American women. They have the worst prognosis of the subtypes. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Basal-like'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/1\">",
"      Bair E, Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2004; 2:E108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/2\">",
"      Prat A, Parker JS, Karginova O, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12:R68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/3\">",
"      Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004; 203:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/4\">",
"      Perou CM, S&oslash;rlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/5\">",
"      Perreard L, Fan C, Quackenbush JF, et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res 2006; 8:R23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/6\">",
"      S&oslash;rlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98:10869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/7\">",
"      Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003; 100:8418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/8\">",
"      Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003; 100:10393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/9\">",
"      Yu K, Lee CH, Tan PH, Tan P. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res 2004; 10:5508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/10\">",
"      Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/11\">",
"      Fan C, Oh DS, Wessels L, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006; 355:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/12\">",
"      Hu Z, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006; 7:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/13\">",
"      Loi S, Haibe-Kains B, Desmedt C, et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 2007; 25:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/14\">",
"      Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010; 28:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/15\">",
"      O'Brien KM, Cole SR, Tse CK, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 2010; 16:6100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/16\">",
"      Foulkes WD, Brunet JS, Stefansson IM, et al. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res 2004; 64:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/17\">",
"      Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003; 95:1482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/18\">",
"      Olopade OI, Grushko T. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001; 344:2028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/19\">",
"      Parker JS, Mullins M, Cheang MC, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; 27:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/20\">",
"      Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295:2492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/21\">",
"      Millikan RC, Newman B, Tse CK, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008; 109:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/22\">",
"      Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 2007; 110:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/23\">",
"      Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007; 109:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/24\">",
"      Lund MJ, Trivers KF, Porter PL, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 2009; 113:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/25\">",
"      Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007; 13:2329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/26\">",
"      Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005; 11:5678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41302/abstract/27\">",
"      Teschendorff AE, Miremadi A, Pinder SE, et al. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol 2007; 8:R157.",
"     </a>",
"    </li>",
"    <li>",
"     Dowsett M, Lopez-Knowles E, Sidhu K, et al. Comparison of PAM50 Risk of Recurrence (ROR) Score with OncotypeDx and IHC4 for Predicting Residual Risk of RFS and Distant-(D)RFS after Endocrine Therapy: A TransATAC Study (Abstract S4-5). Presented at the 2011 San Antonio Breast Cancer Symposium 2011.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 770 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-05A77B525D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41302=[""].join("\n");
var outline_f40_21_41302=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MOLECULAR PROFILING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Technical aspects and limitations of profiling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Unsupervised and supervised analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      BREAST CANCER INTRINSIC SUBTYPES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Luminal subtypes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      HER2-enriched",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1133231165\">",
"      ER-negative subtypes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Basal-like",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H366660450\">",
"      - Claudin-low",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1133231208\">",
"      - Interferon-rich/immunomodulatory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1133231218\">",
"      - Androgen receptor-driven",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1133231226\">",
"      - Normal-like",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1133231104\">",
"      CLINICAL CHARACTERIZATION OF MOLECULAR SUBTYPES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/770\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/770|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/39/14967\" title=\"figure 1\">",
"      Gene exp array meth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11384?source=related_link\">",
"      Adjuvant medical therapy for HER2-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/40/34441?source=related_link\">",
"      Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/28/43465?source=related_link\">",
"      Measurement of prognostic factors in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=related_link\">",
"      Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/22/6503?source=related_link\">",
"      Prognostic molecular profiles of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/43/22202?source=related_link\">",
"      Systemic treatment for metastatic breast cancer: Molecular targeted therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_21_41303="Pharmacology and toxicity of thionamides";
var content_f40_21_41303=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pharmacology and toxicity of thionamides",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41303/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41303/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41303/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41303/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41303/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41303/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/21/41303/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thionamide compounds were found in 1943 to inhibit thyroid hormone synthesis. They are actively transported into the thyroid gland where they inhibit both the organification of iodine to tyrosine residues in thyroglobulin and the coupling of iodotyrosines (",
"    <a class=\"graphic graphic_figure graphicRef76931 \" href=\"mobipreview.htm?26/29/27088\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pharmacology and toxicity of PTU and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    will be reviewed here. Specific issues related to their use in the treatment of Graves' disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/25/12696?source=see_link\">",
"     \"Thionamides in the treatment of Graves' disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOKINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/9/5271?source=see_link\">",
"     Propylthiouracil",
"    </a>",
"    (PTU) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    (Tapazole&reg;, MMI) are the thionamide drugs available in the United States. Carbimazole (CBZ) is a third option available in some European and Asian countries. MMI and CBZ are interchangeable, because CBZ is completely metabolized to MMI. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Regimens'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    PTU but not MMI inhibits the 5'-monodeiodinase that converts thyroxine (T4) to triiodothyronine (T3) in extrathyroidal tissue. However, MMI has several important pharmacokinetic advantages over PTU:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The serum half-life of MMI is four to six hours, whereas that of PTU is 75 minutes.",
"     </li>",
"     <li>",
"      The intrathyroidal MMI concentration, which can reach a thyroid-to-serum ratio of 100:1, remains high for up to 20 hours, considerably longer than that of PTU.",
"     </li>",
"     <li>",
"      Perchlorate discharge tests, which are a measure of inhibition of iodine organification, demonstrate the superiority of MMI over PTU. In one study, perchlorate discharged 37 percent of the radioiodine tracer 24 hours after a single 15 mg dose of MMI, versus only 8.6 percent after a 300 mg dose of PTU [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical trials have demonstrated that MMI is effective when given once daily [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Single daily dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    is more effective than single daily dose PTU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/5\">",
"     5",
"    </a>",
"    ], and PTU is more effective when given in divided doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the theoretical advantage of PTU in blocking the extrathyroidal conversion of T4 to T3, there is evidence of the superiority of MMI in the long-term therapy of hyperthyroidism.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, for example, patients given 10 mg MMI TID had normal serum thyroid hormone concentration an average of 5.8 weeks after beginning therapy as compared with 16.8 weeks in patients given 100 mg PTU TID (",
"      <a class=\"graphic graphic_figure graphicRef54732 \" href=\"mobipreview.htm?28/35/29245\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef76366 \" href=\"mobipreview.htm?19/62/20459\">",
"       table 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second study in which patients were treated with single daily doses of MMI or PTU for 12 weeks, serum T3 concentrations were lower after four weeks and both serum T3 and T4 concentrations were lower after eight weeks and 12 weeks in the MMI group [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/6\">",
"       6",
"      </a>",
"      ]. Patients given MMI become euthyroid in three to eight weeks because it (and PTU) blocks new hormone synthesis, and any already formed T4 and T3 stored in the colloid must be secreted and metabolized for clinical improvement to occur.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MMI is less likely than PTU to be associated with failure of radioiodine therapy when thionamides are given to normalize thyroid function before radioiodine treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Seventy-eight percent of patients pretreated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    and only 32 percent of patients pretreated with PTU were cured by a 10 mCi dose of radioiodine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/8\">",
"     8",
"    </a>",
"    ]. MMI is also easier for patients to take. It is available as 5, 10 and 20 mg tablets, whereas PTU is available only as 50 mg tablets. This means that even large daily doses of MMI require fewer tablets than a small dose of PTU (",
"    <a class=\"graphic graphic_table graphicRef76366 \" href=\"mobipreview.htm?19/62/20459\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     REGIMENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/9/5271?source=see_link\">",
"     propylthiouracil",
"    </a>",
"    (PTU) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    (Tapazole&reg;, MMI) are the thionamides drugs available in the United States. Carbimazole (CBZ), a third drug which is metabolized to MMI, is available in some European and Asian countries. The dose of CBZ is about 40 percent more than comparable doses of MMI.",
"   </p>",
"   <p>",
"    Rectal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] and intravenous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/11,12\">",
"     11,12",
"    </a>",
"    ] administration of MMI and PTU is also possible in selected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Choice of drug",
"    </span>",
"    &nbsp;&mdash;&nbsp;As described above, although both drugs are effective for hyperthyroidism, MMI has some advantages over PTU, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      More rapid achievement of euthyroidism",
"     </li>",
"     <li>",
"      Once-daily dosing and better compliance",
"     </li>",
"     <li>",
"      Little or no effect on subsequent success of radioiodine therapy (unlike PTU, which is associated with an increase in radioiodine failure rates)",
"     </li>",
"     <li>",
"      Less toxicity (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Hepatotoxicity'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accumulating evidence on PTU-associated hepatotoxicity, particularly in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/13\">",
"     13",
"    </a>",
"    ], has led to changes in recommendations for the use of antithyroid drugs. At a joint meeting of the American Thyroid Association and US Food and Drug Administration, it was recommended that PTU",
"    <strong>",
"     not",
"    </strong>",
"    be prescribed as a first-line drug in children or adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there are three clinical settings where we suggest PTU instead of MMI including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In pregnant women during their first trimester (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42760?source=see_link&amp;anchor=H7#H7\">",
"       \"Hyperthyroidism during pregnancy: Treatment\", section on 'Choice of drug'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      In patients with life-threatening thyrotoxicosis or thyroid storm (because of PTU's ability to inhibit peripheral conversion of T4 to T3) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33655?source=see_link&amp;anchor=H4#H4\">",
"       \"Thyroid storm\", section on 'Thionamides'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      In patients with adverse reactions to MMI (other than agranulocytosis) who are not candidates for radioiodine or surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to initiating thionamides, we obtain baseline blood tests, including a complete blood count (white count with differential) and a liver profile (bilirubin and transaminases) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/16\">",
"     16",
"    </a>",
"    ]. We do not use thionamides in patients with a baseline absolute neutrophil count &lt;500 mm3 or elevated liver transaminases (more than fivefold the upper limit of normal) except in selected patients after careful assessment of alternatives and risks.",
"   </p>",
"   <p>",
"    The starting dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    varies according to the severity of the hyperthyroidism. Patients with small goiters and mild hyperthyroidism can be started on 10 to 15 mg once daily. The dose can be increased if the hyperthyroidism (as assessed clinically and by measurements of serum thyrotropin [TSH], T4, and T3) is not ameliorated within four to six weeks.",
"   </p>",
"   <p>",
"    Patients with larger goiters and more severe hyperthyroidism should be started on 20 to 30 mg daily. Few patients require more than 40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of MMI. We administer initial therapy in divided doses (eg, 10 mg twice or three times a day or 15 mg twice daily) to minimize gastrointestinal side effects, and then change to single daily dosing if tolerated and as the dose is reduced. The carbimazole dose required to yield an equivalent dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    is approximately 40 percent higher. For example, a 10 or 20 mg dose of carbimazole yields roughly 6 and 15 mg of methimazole, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/25/12696?source=see_link&amp;anchor=H4#H4\">",
"     \"Thionamides in the treatment of Graves' disease\", section on 'Dosing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study of over 300 patients randomized to MMI 30",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    MMI 15",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    or PTU 300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    the following results were seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At 12 weeks, the percentage of patients with normal free T4 levels was 97, 86, and 78 percent in the MMI 30 mg, MMI 15 mg, and PTU 300 mg groups, respectively.",
"     </li>",
"     <li>",
"      Among patients with initial free T4 concentrations equal to or greater than 7",
"      <span class=\"nowrap\">",
"       ng/mL,",
"      </span>",
"      MMI 30",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      normalized free T4 more rapidly than MMI 15",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      or PTU 300",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"      However, among patients with free T4 concentrations less than 7",
"      <span class=\"nowrap\">",
"       ng/mL,",
"      </span>",
"      there was no difference among the regimens.",
"     </li>",
"     <li>",
"      Serum T3 levels were normalized more quickly with either MMI dose compared with PTU, despite PTU&rsquo;s ability to block T4 to T3 conversion, indicating that this effect is more important in the short term rather than over many weeks.",
"     </li>",
"     <li>",
"      Side effects were seen in 30, 14, and 52 percent of patients taking MMI 30 mg, MMI 15 mg, and PTU, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data are supported by older studies. For example, patients given MMI in doses of 15 mg once daily, 30 mg once daily, or 10 mg three times daily became euthyroid in the same average time (",
"    <a class=\"graphic graphic_figure graphicRef82645 \" href=\"mobipreview.htm?37/17/38173\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/3\">",
"     3",
"    </a>",
"    ], while in a randomized trial in 509 patients the response to 40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of MMI was somewhat more rapid than that to 10",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Our dose recommendations are also influenced by the dose-dependence of the major side effects of MMI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TOXICITY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Common side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both MMI and PTU can cause pruritus, rash, urticaria, arthralgias, arthritis, fever, abnormal taste sensation, nausea, or vomiting in up to 13 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/20\">",
"     20",
"    </a>",
"    ]. Mild skin reactions can be treated with antihistamine therapy without stopping MMI or PTU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/16\">",
"     16",
"    </a>",
"    ], with the caveat that some skin reactions from PTU may be indicative of vasculitis. If one drug is not tolerated, the other drug can be substituted, but up to 50 percent of patients have cross-sensitivity. For patients with serious allergic reactions, prescribing the alternative drug is not recommended. The gastrointestinal side effects are dose-dependent. Thus, patients taking higher doses of MMI should be started on divided doses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Potential teratogenicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;MMI has been associated with a rare fetal scalp defect, aplasia cutis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/31/15864?source=see_link&amp;anchor=H19#H19\">",
"     \"Vesiculobullous and pustular lesions in the newborn\", section on 'Aplasia cutis congenita'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More serious congenital malformations such as choanal atresia and tracheoesophageal fistulas (so-called",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    embryopathy) have also been associated with MMI. This topic is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42760?source=see_link&amp;anchor=H5#H5\">",
"     \"Hyperthyroidism during pregnancy: Treatment\", section on 'Thionamides'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Agranulocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agranulocytosis is a rare but serious complication of thionamide therapy, with a prevalence of 0.1 to 0.5 percent, and usually occurs within the first two months of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In one study from Japan, the average time to onset of agranulocytosis was 69 days (range 11 to 233 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/23\">",
"     23",
"    </a>",
"    ]. The risk of agranulocytosis is higher for antithyroid drugs than for 20 other classes of drugs associated with this rare complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/24\">",
"     24",
"    </a>",
"    ]. In one study, agranulocytosis was more frequent in elderly patients taking MMI in doses higher than 40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/25\">",
"     25",
"    </a>",
"    ], while in another study agranulocytosis was more common with doses &gt;20 mg daily versus 5 to 15 mg daily [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/24\">",
"     24",
"    </a>",
"    ] and in a third study no cases were seen with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    doses under 30 mg and the prevalence of agranulocytosis with PTU was dose-independent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the UK, reports of agranulocytosis are more common with PTU than carbimazole [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/26\">",
"     26",
"    </a>",
"    ]. Most cases occur within three months after treatment is begun. However, a Japanese study found that the development of agranulocytosis was independent of dose, age, duration of treatment, or second exposure to the thionamide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Controversy exists as to the value of monitoring white blood cell counts. Most clinicians in the United States do not recommend periodic monitoring, and the ATA guidelines do not recommend monitoring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/16\">",
"     16",
"    </a>",
"    ]. However, a study from Japan was able to identify 78 percent of cases of granulocytopenia before the onset of symptoms by checking blood counts every two weeks for the first two months of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/28\">",
"     28",
"    </a>",
"    ]. We advise patients taking a thionamide to have an immediate white cell count with differential at the earliest sign of a sore throat or other infection, and to discontinue the drug until the result is available.",
"   </p>",
"   <p>",
"    Recovery from agranulocytosis takes a few days, but morbidity and death from serious infections can occur.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/13/23767?source=see_link\">",
"     Granulocyte colony-stimulating factor",
"    </a>",
"    (G-CSF) has been used as adjunctive therapy in severe cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/29\">",
"     29",
"    </a>",
"    ], but its efficacy is uncertain. As an example, in a nonrandomized prospective controlled trial of 24 patients with a thionamide-induced neutrophil count of less than",
"    <span class=\"nowrap\">",
"     500/&micro;L,",
"    </span>",
"    there was no difference in the time to neutrophil recovery between those who received G-CSF versus those who did not, suggesting that the therapy did not affect the course of agranulocytosis, especially in the most severe cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/30\">",
"     30",
"    </a>",
"    ]. Glucocorticoid therapy is ineffective. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21850?source=see_link\">",
"     \"Drug-induced neutropenia and agranulocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Aplastic anemia is an additional rare complication of thionamides [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     ANCA-positive vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;An antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis has been reported in association with PTU use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]. There is also a possible association between",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    and ANCA-positive vasculitis, but the number of cases is too small to establish a cause-and-effect relationship. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/28/9674?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical spectrum of antineutrophil cytoplasmic antibodies\", section on 'Drug-induced ANCA-associated vasculitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of ANCA-positivity in patients taking PTU may be more widespread than previously thought as illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, 21 of 56 patients (38 percent) taking PTU were ANCA-positive, compared with none of 21 taking MMI and none of 42 untreated patients. Nine of these patients had arthralgias or myalgias, but 12 were asymptomatic and none had renal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another report, 64 percent of children taking PTU were ANCA-positive, compared with none taking MMI; none of the ANCA-positive patients had clinical evidence of vasculitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report of 19 hospitalized patients with ANCA-positive PTU-associated vasculitis, 15 had renal involvement, and 10 of those had necrotizing crescentic glomerulonephritis on renal biopsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A European study compared 407 patients with Graves' disease to 649 euthyroid controls and found an increased prevalence of ANCA in Graves' patients compared with controls (19.9 versus 4.6 percent for ANCA and 3.1 versus 1.1 percent for myeloperoxidase ANCA (MPO-ANCA) in the Graves' and control groups, respectively) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/39\">",
"       39",
"      </a>",
"      ]. In addition, ANCA prevalence was more strongly associated with PTU than carbimazole as 33 percent of Graves' patients receiving PTU were ANCA-positive compared to 16 percent of those receiving carbimazole.",
"     </li>",
"     <li>",
"      Another European study found a similar prevalence of ANCA-positive patients among those with Graves&rsquo; disease (43 percent) or toxic nodular goiter (38 percent) treated with PTU [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a small prospective trial of patients with Graves' hyperthyroidism who were ANCA negative at baseline, 32 percent treated with PTU became ANCA positive at a mean of 12 months after starting therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since the majority of ANCA positive patients have no clinical symptoms of vasculitis, the significance of this finding is uncertain, and we only assess ANCA levels in those patients who have symptoms consistent with possible vasculitis. On the other hand, this is one of several reasons why we strongly prefer the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    or carbimazole rather than PTU.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hepatotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatotoxicity is a rare complication of thionamide therapy. Serum transaminase concentrations increase transiently in up to one-third of patients taking PTU; this abnormality may be associated with focal hepatic necrosis on liver biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/42\">",
"     42",
"    </a>",
"    ]. A literature survey published in 1997 reported 49 cases of hepatotoxicity, 28 associated with PTU (including 7 deaths) and 21 associated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    (including three deaths) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/43\">",
"     43",
"    </a>",
"    ]. There was no relationship between a fatal outcome and either the dose or duration of thionamide treatment.",
"   </p>",
"   <p>",
"    However, additional reports of severe PTU-related liver failure from the FDA Adverse Event Reporting System have raised concern about the routine use of PTU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/14,44\">",
"     14,44",
"    </a>",
"    ]. Over the past 20 years, 22 cases of severe hepatotoxicity in adults in the US resulted in nine deaths and five liver transplants. Over the same period, 12 children developed liver failure resulting in three deaths and six liver transplants. It was estimated that this complication occurs in 1:10,000 adults taking PTU, with an even greater risk in children (1:2000) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. PTU-related hepatotoxicity typically occurs within 90 days of starting the medication (although cases occurring up to one year have been reported), and it is not dose-related.",
"   </p>",
"   <p>",
"    Patients taking PTU or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    who develop jaundice, dark urine, light stools, abdominal pain, anorexia, nausea, or other evidence of hepatic dysfunction should be told to discontinue the drug immediately and to contact the clinician for assessment of liver function (transaminases, bilirubin) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/16\">",
"     16",
"    </a>",
"    ]. PTU should not be used if transaminases reach two to three times the upper limit of normal and fail to improve on repeat testing one week later. After discontinuation, liver function tests should be monitored weekly until normalization. If they do not normalize, immediate referral to a hepatologist or gastroenterologist may be necessary. MMI may be substituted for PTU, except in cases of severe PTU-induced hepatotoxicity.",
"   </p>",
"   <p>",
"    Although MMI has been associated with liver disease, it is typically due to cholestatic dysfunction not hepatocellular inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These data have led to changes in recommendations for the use of antithyroid drugs. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Choice of drug'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H953180\">",
"    <span class=\"h2\">",
"     Pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatitis has very rarely been reported in association with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/9/22674?source=see_link\">",
"       \"Patient information: Hyperthyroidism (overactive thyroid) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/6/3172?source=see_link\">",
"       \"Patient information: Hyperthyroidism (overactive thyroid) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/15/23794?source=see_link\">",
"       \"Patient information: Antithyroid drugs (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     Methimazole",
"    </a>",
"    has clinical advantages (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Pharmacokinetics'",
"    </a>",
"    above) and less severe toxicity when compared with PTU. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Common side effects'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/25/12696?source=see_link\">",
"     \"Thionamides in the treatment of Graves' disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"       Methimazole",
"      </a>",
"      (or carbimazole) are currently considered first-line drugs because of serious liver injury reports in patients taking",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/9/5271?source=see_link\">",
"       propylthiouracil",
"      </a>",
"      (PTU). An exception would be during the first trimester of pregnancy when PTU is preferred because of the potential teratogenic effects of methimazole, and during life-threatening thyrotoxicosis or thyroid storm (because of PTU's ability to inhibit peripheral conversion of T4 to T3). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Choice of drug'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with small goiters and mild hyperthyroidism should be started on 10 to 15 mg of MMI daily. The dose can be increased if the hyperthyroidism (as assessed clinically and by measurements of serum thyrotropin [TSH], T4, T3) is not ameliorated within four to six weeks. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Dosing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      On the other hand, patients with larger goiters and more severe hyperthyroidism should be started on 20 to 40 mg daily. We administer therapy initially in divided doses to possibly minimize gastrointestinal side effects, and then change to single daily dosing if tolerated and as the dose is reduced. Few patients require more than 40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of MMI. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Dosing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both MMI and PTU can cause pruritus, rash, urticaria, arthralgias, arthritis, fever, abnormal taste sensation, nausea, or vomiting in up to 13 percent of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41303/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Common side effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Agranulocytosis is a rare but serious complication of thionamide therapy, with a prevalence of 0.1 to 0.5 percent. We advise patients taking a thionamide to have a white cell count with differential at the earliest sign of a sore throat or other infection, and to discontinue the drug until the result is available. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Agranulocytosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients taking PTU or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"       methimazole",
"      </a>",
"      who develop jaundice, dark urine, light stools, or other evidence of hepatic dysfunction should be told to discontinue the drug immediately and to contact the clinician for assessment of liver function. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Hepatotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/1\">",
"      Cooper DS. Antithyroid drugs. N Engl J Med 2005; 352:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/2\">",
"      Okamura K, Ikenoue H, Shiroozu A, et al. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab 1987; 65:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/3\">",
"      Shiroozu A, Okamura K, Ikenoue H, et al. Treatment of hyperthyroidism with a small single daily dose of methimazole. J Clin Endocrinol Metab 1986; 63:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/4\">",
"      Mashio Y, Beniko M, Ikota A, et al. Treatment of hyperthyroidism with a small single daily dose of methimazole. Acta Endocrinol (Copenh) 1988; 119:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/5\">",
"      He CT, Hsieh AT, Pei D, et al. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf) 2004; 60:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/6\">",
"      Homsanit M, Sriussadaporn S, Vannasaeng S, et al. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Clin Endocrinol (Oxf) 2001; 54:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/7\">",
"      Imseis RE, Vanmiddlesworth L, Massie JD, et al. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998; 83:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/8\">",
"      Santos RB, Romaldini JH, Ward LS. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. Thyroid 2004; 14:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/9\">",
"      Nabil N, Miner DJ, Amatruda JM. Methimazole: an alternative route of administration. J Clin Endocrinol Metab 1982; 54:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/10\">",
"      Walter RM Jr, Bartle WR. Rectal administration of propylthiouracil in the treatment of Graves' disease. Am J Med 1990; 88:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/11\">",
"      Hodak SP, Huang C, Clarke D, et al. Intravenous methimazole in the treatment of refractory hyperthyroidism. Thyroid 2006; 16:691.",
"     </a>",
"    </li>",
"    <li>",
"     Gregoire, G, Aris-Jilwan, N, Ninet, B, et al. Intravenous administration of propylthiouracil in treatment of a patient with Graves' disease (abstract). 77th Annual Meeting, The Endocrine Society, 1995, Abstract P3-464.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/13\">",
"      Rivkees SA, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 2010; 95:3260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/14\">",
"      Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009; 94:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/15\">",
"      Bahn RS, Burch HS, Cooper DS, et al. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009; 19:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/16\">",
"      Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011; 21:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/17\">",
"      Jansson R, Dahlberg PA, Lindstr&ouml;m B. Comparative bioavailability of carbimazole and methimazole. Int J Clin Pharmacol Ther Toxicol 1983; 21:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/18\">",
"      Nakamura H, Noh JY, Itoh K, et al. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2007; 92:2157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/19\">",
"      Benker G, Vitti P, Kahaly G, et al. Response to methimazole in Graves' disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) 1995; 43:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/20\">",
"      Werner MC, Romaldini JH, Bromberg N, et al. Adverse effects related to thionamide drugs and their dose regimen. Am J Med Sci 1989; 297:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/21\">",
"      Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001; 86:2354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/22\">",
"      Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007; 146:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/23\">",
"      Watanabe N, Narimatsu H, Noh JY, et al. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. J Clin Endocrinol Metab 2012; 97:E49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/24\">",
"      van Staa TP, Boulton F, Cooper C, et al. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol 2003; 72:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/25\">",
"      Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 1983; 98:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/26\">",
"      Pearce SH. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf) 2004; 61:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/27\">",
"      Tamai H, Takaichi Y, Morita T, et al. Methimazole-induced agranulocytosis in Japanese patients with Graves' disease. Clin Endocrinol (Oxf) 1989; 30:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/28\">",
"      Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 1990; 150:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/29\">",
"      Balkin MS, Buchholtz M, Ortiz J, Green AJ. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Thyroid 1993; 3:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/30\">",
"      Fukata S, Kuma K, Sugawara M. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 1999; 9:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/31\">",
"      Thomas D, Moisidis A, Tsiakalos A, et al. Antithyroid drug-induced aplastic anemia. Thyroid 2008; 18:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/32\">",
"      Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999; 84:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/33\">",
"      Kitahara T, Hiromura K, Maezawa A, et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol 1997; 47:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/34\">",
"      Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/35\">",
"      Tanemoto M, Miyakawa H, Hanai J, et al. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases. Am J Kidney Dis 1995; 26:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/36\">",
"      Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 2000; 10:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/37\">",
"      Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab 2000; 85:4270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/38\">",
"      Yu F, Chen M, Gao Y, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis 2007; 49:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/39\">",
"      Harper L, Chin L, Daykin J, et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol (Oxf) 2004; 60:671.",
"     </a>",
"    </li>",
"    <li>",
"     Yazisz, V, Ongut, G, Terzioglu, E, Karayalcin, U. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. Int J Clin Pract 2008; [Epub ahead of print].",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/41\">",
"      Cin MO, Gursoy A, Morris Y, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil. Int J Clin Pract 2009; 63:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/42\">",
"      Liaw YF, Huang MJ, Fan KD, et al. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med 1993; 118:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/43\">",
"      Williams KV, Nayak S, Becker D, et al. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 1997; 82:1727.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil, April 2010. file://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm209023.htm (Accessed on April 22, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/45\">",
"      Arab DM, Malatjalian DA, Rittmaster RS. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab 1995; 80:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41303/abstract/46\">",
"      Yang M, Qu H, Deng HC. Acute pancreatitis induced by methimazole in a patient with Graves' disease. Thyroid 2012; 22:94.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7875 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-FF4A722CD6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41303=[""].join("\n");
var outline_f40_21_41303=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOKINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Choice of drug",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Dosing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Common side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Potential teratogenicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Agranulocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ANCA-positive vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hepatotoxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H953180\">",
"      Pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7875\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7875|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/29/27088\" title=\"figure 1\">",
"      Thyroid hormone synthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/35/29245\" title=\"figure 2\">",
"      Methimazole versus PTU",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/17/38173\" title=\"figure 3\">",
"      Methimazole dose response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7875|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/62/20459\" title=\"table 1\">",
"      Antithyroid drug comparisons",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/28/9674?source=related_link\">",
"      Clinical spectrum of antineutrophil cytoplasmic antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21850?source=related_link\">",
"      Drug-induced neutropenia and agranulocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42760?source=related_link\">",
"      Hyperthyroidism during pregnancy: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/15/23794?source=related_link\">",
"      Patient information: Antithyroid drugs (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?3/6/3172?source=related_link\">",
"      Patient information: Hyperthyroidism (overactive thyroid) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/9/22674?source=related_link\">",
"      Patient information: Hyperthyroidism (overactive thyroid) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/25/12696?source=related_link\">",
"      Thionamides in the treatment of Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33655?source=related_link\">",
"      Thyroid storm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/31/15864?source=related_link\">",
"      Vesiculobullous and pustular lesions in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_21_41304="Undiff nasopharyngeal CA Light";
var content_f40_21_41304=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 567px\">",
"   <div class=\"ttl\">",
"    Nasopharyngeal carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 547px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power photomicrograph of an undifferentiated type of nasopharyngeal carcinoma (lymphoepithelioma), characterized by large atypical cells (black arrow) in a sea of lymphocytes (left panel). Cytokeratin immunostains highlight more tumor cells than are apparent in routinely stained sections (right panel), and may be required to exclude lymphoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of G Kenneth Haines, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41304=[""].join("\n");
var outline_f40_21_41304=null;
var title_f40_21_41305="Overview of electroconvulsive therapy (ECT) for adults";
var content_f40_21_41305=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of electroconvulsive therapy (ECT) for adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41305/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41305/contributors\">",
"     Charles Kellner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41305/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41305/contributors\">",
"     Peter P Roy-Byrne, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/21/41305/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/21/41305/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/21/41305/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 31, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electroconvulsive therapy (ECT) uses a small electric current to produce a generalized cerebral seizure under general anesthesia. ECT is used mainly to treat severe depression, but is also indicated for patients with other conditions, including bipolar disorder, schizophrenia, schizoaffective disorder, delirium, and neuroleptic malignant syndrome.",
"   </p>",
"   <p>",
"    There is no question about the efficacy and safety of ECT, which is practiced widely in the United States and the rest of the world [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/1\">",
"     1",
"    </a>",
"    ]. Nevertheless, it remains controversial and stigmatized because of misinformation and outmoded perceptions about how the treatment is performed.",
"   </p>",
"   <p>",
"    This topic provides an overview of ECT. The indications for treating unipolar major depression with ECT, the efficacy of ECT for treating unipolar depression, technique for performing ECT, and medical consultation for ECT are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41416?source=see_link\">",
"       \"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=see_link\">",
"       \"Technique for performing electroconvulsive therapy (ECT) in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link\">",
"       \"Medical consultation for electroconvulsive therapy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY OF ECT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of seizures to treat psychiatric disorders has progressed over time, and began with observations that schizophrenic patients often improved temporarily after a spontaneous seizure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Initially, physicians induced seizures with medications. In 1938, Italian psychiatrists used an electric current to induce seizures as a treatment for schizophrenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/5\">",
"     5",
"    </a>",
"    ]. ECT quickly spread around Europe and the rest of the world, and was first used in the United States in 1939. Patients suffered bone fractures occasionally and considerable anticipatory anxiety, but advances in anesthesia techniques in the 1950s allowed for the use of general anesthesia and muscle relaxation for ECT, which reduced the incidence of these problems.",
"   </p>",
"   <p>",
"    The use of ECT in the United States has fluctuated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/6\">",
"     6",
"    </a>",
"    ]. Use of ECT declined in the 1970s, and subsequently increased, possibly as a result of greater treatment resistance to pharmacotherapy in depressed patients, increased recognition of the limitations of pharmacotherapy, and better public acceptance. A practice survey from 1988-89 estimated that at least 100,000 patients received ECT annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/7\">",
"     7",
"    </a>",
"    ]. The typical ECT patient today is relatively affluent and receives ECT in a private sector psychiatric facility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/6\">",
"     6",
"    </a>",
"    ]. State hospitals rarely offer the treatment, even though many of the patients would meet indications for ECT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of action for ECT is unknown, but there are many well-documented changes in the central nervous system:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Human and animal studies show that ECT increases release of monoamine neurotransmitters, particularly dopamine and serotonin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/8-10\">",
"       8-10",
"      </a>",
"      ]. ECT also enhances monoamine transmission by desensitizing presynaptic adrenergic autoreceptors.",
"     </li>",
"     <li>",
"      One theory postulates that ECT exerts its beneficial effects by increasing release of central neuropeptides, including corticotrophin releasing factor, somatostatin (STS), and neuropeptide Y [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The neuroendocrine hypothesis is based upon the",
"      <span class=\"nowrap\">",
"       diabetes/insulin",
"      </span>",
"      model and suggests that mood disorders are caused by insufficiency of a hypothalamic mood-maintaining peptide [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/12\">",
"       12",
"      </a>",
"      ]. Repeated seizures enhance the production and release of the putative hypothalamic peptide antidepression, which relieves both neuroendocrine and behavioral abnormalities.",
"     </li>",
"     <li>",
"      ECT has anticonvulsant properties (perhaps related to enhanced gamma-aminobutyric acid transmission), which has led to the suggestion that these properties are responsible for the therapeutic effects of the treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Positron emission tomography (PET) studies demonstrate decreased metabolic activity in frontal and cingulate cortex after ECT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Functional magnetic resonance imaging before and after successful treatment with ECT reveals a reduction in global connectivity within the left dorsal lateral prefrontal cortex [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/15\">",
"       15",
"      </a>",
"      ]. Quantitative electroencephalogram (EEG) studies demonstrate increased slow (delta) wave activity in the prefrontal cortex after ECT, which is associated with clinical response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Several human and animal studies indicate that ECT has trophic effects on the central nervous system [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/17-21\">",
"       17-21",
"      </a>",
"      ]. ECT increases brain derived neurotrophic factor (BDNF) in patients and electroconvulsive stimulation induces neurogenesis and mossy fibre sprouting from granule cells in rat hippocampus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PRE-ECT EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of the pre-ECT evaluation are to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Determine whether ECT is indicated (",
"      <a class=\"graphic graphic_table graphicRef55438 \" href=\"mobipreview.htm?15/8/15499\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41416?source=see_link\">",
"       \"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Establish baseline psychiatric and cognitive status to serve as reference points for evaluating response and cognitive effects. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Clinical monitoring'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Identify and treat any general medical conditions that might be associated with an increased risk of adverse events from ECT (",
"      <a class=\"graphic graphic_table graphicRef55652 \" href=\"mobipreview.htm?33/11/33981\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Specific medical conditions'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Initiate and continue the informed consent process. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Informed consent'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A complete medical history should be taken. Medical consultation prior to ECT is indicated for most patients 40 years or older, and is frequently obtained in younger patients as well. Particular attention should be paid to any history of cardiopulmonary disease and prior surgeries (with inquiry about type of anesthesia and any complications). A history of skull fractures should be determined, as this may affect electrode placement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link\">",
"     \"Medical consultation for electroconvulsive therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=see_link&amp;anchor=H6#H6\">",
"     \"Technique for performing electroconvulsive therapy (ECT) in adults\", section on 'Electrode placement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Appropriate physical examination and laboratory evaluation, guided by the relevant history, should be performed. The patient's handedness and any dental problems should be noted. Specific laboratory tests are not indicated for patients without known medical comorbidities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=see_link\">",
"     \"Preoperative medical evaluation of the healthy patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SPECIFIC MEDICAL CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inducing a seizure causes transient increases in blood pressure, pulse, and intracranial pressure, which can have deleterious effects. Organ systems of most concern are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cardiovascular",
"     </li>",
"     <li>",
"      Pulmonary",
"     </li>",
"     <li>",
"      Central nervous system",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Seizures increase cardiac workload and oxygen demand. Thus, it is important to try to maximize the patient's cardiovascular status before ECT. Additionally, medication to blunt increases in heart rate and blood pressure is indicated prior to ECT and during the procedure in patients for whom these increases would be detrimental. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H12#H12\">",
"     \"Medical consultation for electroconvulsive therapy\", section on 'Prophylactic beta blockers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Coronary heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac complications are the most common cause of serious morbidity and mortality during ECT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with coronary heart disease should be evaluated prior to ECT with a careful cardiac history and ECG. Additional cardiovascular diagnostic testing and evaluation by a cardiology consultant may be indicated for selected patients, and for any patient with unstable disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     History of myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;History of myocardial infarction and current unstable angina present increased risk. Careful consideration of the",
"    <span class=\"nowrap\">",
"     risk/benefit",
"    </span>",
"    ratio of ECT in such cases is essential. The key factors in this assessment are the extent of myocardial damage and subsequent healing, and the residual functional cardiac status.",
"   </p>",
"   <p>",
"    In general, the longer one waits after a myocardial infarction, the safer it is to perform ECT. For patients who have had a myocardial infarction and are not at imminent risk from their depressive episode, we suggest waiting a minimum of three months prior to starting a course of ECT. However, patients at high risk of death due to their depression can be treated sooner. For severely depressed patients, treatment with ECT on an emergent basis may be indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's blood pressure should be well controlled prior to ECT. The patient should take his or her currently prescribed antihypertensive medications (with the exception of diuretics) with a small sip of water, prior to each ECT treatment.",
"   </p>",
"   <p>",
"    Use of prophylactic beta blockers to prevent treatment-induced hypertension is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H10#H10\">",
"     \"Medical consultation for electroconvulsive therapy\", section on 'Strategies to reduce the risk of cardiac complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Heart failure and valvular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of ECT in patients with heart failure or valvular disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H17#H17\">",
"     \"Medical consultation for electroconvulsive therapy\", section on 'Heart failure and valvular disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pacemakers and implantable defibrillators",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of ECT in patients with pacemakers or implantable defibrillators is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H18#H18\">",
"     \"Medical consultation for electroconvulsive therapy\", section on 'Pacemakers and implantable defibrillators'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimizing pulmonary status before ECT is important. The anesthesiologist manipulates the patient's airway during ECT using a bag and mask circuit and there is a risk of inducing bronchoconstriction. All patients should receive supplemental oxygen via nasal cannula, initiated a few minutes prior to each treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Elective intubation is not indicated for ECT, except in rare circumstances in which the anesthesiologist assesses that intubation would be exceptionally difficult should the airway become compromised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Neurologic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of ECT for patients with brain tumors, history of stroke, dementia, and neuromuscular disease is discussed separately (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H19#H19\">",
"     \"Medical consultation for electroconvulsive therapy\", section on 'Coexisting neurologic and neurosurgical disease'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CONCURRENT MEDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's current medications, including prescription, over-the-counter, and complementary or alternative drugs should be reviewed prior to ECT. The ECT psychiatrist, anesthesiologist, or medical consultant should decide which to continue and which to taper and discontinue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Psychotropic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many psychotropic medications may be continued during a course of ECT for their synergistic effect without compromising safety, including antidepressants, antipsychotics, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    . Morning doses on the day of ECT are given after the patient has recovered from that day's procedure. Anticonvulsants and benzodiazepines often interfere with ECT and may need to be tapered and discontinued.",
"   </p>",
"   <p>",
"    Antidepressants improve the efficacy of ECT. A review of 10 systematic reviews, 7 meta-analyses, and 3 practice guidelines found that for depressed patients, a tricyclic may improve the antidepressant effect of ECT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/27\">",
"     27",
"    </a>",
"    ]. As an example, a randomized trial assigned 319 depressed patients receiving an acute course of ECT to concomitant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    , or placebo. Remission occurred in more patients who received nortriptyline or venlafaxine compared with placebo (63 and 60 versus 49 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/28\">",
"     28",
"    </a>",
"    ], with a significant difference between nortriptyline and placebo.",
"   </p>",
"   <p>",
"    Antidepressants are generally safe to use with ECT and do not affect its tolerability. As an example, a randomized trial of depressed patients receiving an acute course of ECT with concomitant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    , or placebo found the number of adverse events did not differ significantly between the three groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/28\">",
"     28",
"    </a>",
"    ]. Other types of antidepressants are also well tolerated during ECT, including selective serotonin reuptake inhibitors, tetracyclics, and monoamine oxidase inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antipsychotic medications are often continued during ECT and may provide a synergistic antipsychotic effect, especially second generation antipsychotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/31\">",
"     31",
"    </a>",
"    ]. In addition, antipsychotics generally do not appear to affect the tolerability of ECT. Second generation antipsychotics and high potency first generation antipsychotics are thought to be safe. A review found that early reports warned of hypotension and cardiac complications from combining",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"     chlorpromazine",
"    </a>",
"    and ECT, but later reports did not substantiate these problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/32\">",
"     32",
"    </a>",
"    ]. Nonetheless, combining of low potency, first generation antipsychotics with ECT should be done cautiously.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    has the potential to increase the adverse cognitive effects of ECT and to prolong the effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    (which is typically used during ECT to reduce tonic-clonic movements), but these problems are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/33\">",
"     33",
"    </a>",
"    ]. However, a review of several case series found that concomitant lithium and ECT is safe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/33\">",
"     33",
"    </a>",
"    ]. We suggest reducing lithium levels below the full therapeutic range at the time of each ECT treatment by withholding one or two doses of lithium prior to each treatment.",
"   </p>",
"   <p>",
"    Benzodiazepines should be tapered and discontinued whenever possible during ECT because of their anticonvulsant properties, which can increase seizure threshold, shorten seizure duration, and decrease the intensity of the ECT seizure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/34\">",
"     34",
"    </a>",
"    ]. These effects may decrease the clinical efficacy of ECT.",
"   </p>",
"   <p>",
"    For patients who need to continue their benzodiazepine during ECT, some authorities recommend switching from drugs with a long half-life to one with a short half-life, and withholding the evening dose before each ECT treatment. Small doses of benzodiazepines, however, may not be a problem. Patients who are very anxious about the ECT procedure itself may take a dose of benzodiazepine (eg, 1 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    sublingual) 30 to 60 minutes before the treatment.",
"   </p>",
"   <p>",
"    Anticonvulsants may interfere with the efficacy of ECT, similar to benzodiazepines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/35\">",
"     35",
"    </a>",
"    ]. When anticonvulsants are used for mood stabilization, they generally should be tapered and discontinued prior to ECT.",
"   </p>",
"   <p>",
"    Patients with epilepsy should continue their anticonvulsants during a course of ECT. Clinicians should consider reducing the dose if seizures are difficult to elicit, or withholding a dose the evening or night before the ECT treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other drugs",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiovascular medications &ndash; Patients should receive their routine antihypertensive (other than diuretics) and antianginal medications with a small sip of water approximately two hours before ECT. Diuretics should not be given because it is better to minimize the amount of urine in the bladder during the procedure, to prevent the patient from wetting himself as a result of the seizure.",
"      <br/>",
"      <br/>",
"      Use of cardiovascular medications in patients receiving ECT is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link\">",
"       \"Medical consultation for electroconvulsive therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anticoagulants &ndash; The use of anticoagulant medication in patients receiving ECT is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H25#H25\">",
"       \"Medical consultation for electroconvulsive therapy\", section on 'Anticoagulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypoglycemics &ndash; The use of hypoglycemic medications in patients receiving ECT is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H24#H24\">",
"       \"Medical consultation for electroconvulsive therapy\", section on 'Diabetes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Asthma medications &ndash; Glucocorticoids and beta-adrenergic agonists may be given before ECT, as needed, to prevent bronchoconstriction. Patients who routinely use a fast-acting inhaler should do so immediately before the treatment.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/31/30200?source=see_link\">",
"       Theophylline",
"      </a>",
"      should be avoided or maintained at the lowest effective blood level because it has been associated with prolonged seizures and status epilepticus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Gastrointestinal medications &ndash; Patients with gastroesophageal reflux disease (GERD) should receive their H2 blocker, proton pump inhibitor, or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/13/216?source=see_link\">",
"       metoclopramide",
"      </a>",
"      with a sip of water two hours before ECT to prevent reflux and possible aspiration. Sodium citrate (30 cc po) may be given immediately before treatment to neutralize any acid remaining in the stomach [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INFORMED CONSENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The psychiatrist should ensure that the consent process conforms to all state and local laws and statutes, and hospital policies. Informed consent requires that the patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Receive adequate information about depression and ECT",
"     </li>",
"     <li>",
"      Is capable of understanding and acting reasonably on this information",
"     </li>",
"     <li>",
"      Is given the opportunity to consent in the absence of coercion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ECT consent forms are more detailed compared with those for most other medical procedures because ECT is closely scrutinized. The American Psychiatric Association Task Force report provides a sample template for ECT consent that has been widely adopted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/29\">",
"     29",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef51881 \" href=\"mobipreview.htm?8/57/9118\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef64703 \" href=\"mobipreview.htm?10/22/10606\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Informational material written for the layperson is typically provided to patients and family members as part of obtaining informed consent. In addition, patients and family members may watch video to augment the written material and discussion with the psychiatrist recommending ECT. (See",
"    <a class=\"local\" href=\"#H89471769\">",
"     'Outside sources of patient education'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The vast majority of ECT is done with fully informed consent given by the patient. In circumstances when the patient is too ill (eg, catatonic or psychotic) and lacks capacity to provide consent, and the need for ECT is urgent or emergent, the psychiatrist should seek substitute consent by a court.",
"   </p>",
"   <p>",
"    The patient should be cautioned not to make major personal or financial decisions during or immediately after a course of ECT. In addition, the patient should not drive until the cognitive effects of ECT have resolved. Patients who are receiving continuation or maintenance ECT should not drive until 24 hours after each treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT COURSE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Number of treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no standard number of treatments for an acute ECT course and no way to predict how many treatments a particular patient will need. Most patients remit with 6 to 12 treatments, but some require only three while others require 20 or more [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study of 184 patients with unipolar major depression, the mean number of treatments needed to reach remission was 7 (standard deviation 3) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/38\">",
"     38",
"    </a>",
"    ]. A second study of 230 patients with unipolar or bipolar major depression found that 90 percent or more of the remissions occurred with nine or fewer seizures, depending upon the type of electrode placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=see_link&amp;anchor=H6#H6\">",
"     \"Technique for performing electroconvulsive therapy (ECT) in adults\", section on 'Electrode placement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute ECT should last until the patient remits, reaches an improvement plateau, or develops limiting adverse effects. It is becoming more common to taper the frequency of ECT treatments, rather than abruptly stop a course.",
"   </p>",
"   <p>",
"    Once remission is achieved, however, ongoing continuation and maintenance treatments are frequently indicated. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Continuation and maintenance ECT'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Treatment frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of treatments varies by country and the clinical urgency. Standard practice in the United States is to give ECT three times per week on a Monday-Wednesday-Friday schedule. The routine in many other countries is twice a week, particularly for elderly patients. Urgently ill patients (eg, catatonic or severely malnourished) may be given daily bilateral ECT until some improvement is evident [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Meta-analyses of five randomized trials (169 patients with unipolar major depression) found that symptomatic improvement, remission, and number of ECT treatments were comparable for twice-weekly and thrice-weekly ECT; however, duration of treatment was significantly longer for twice-weekly ECT (by nearly five days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/40\">",
"     40",
"    </a>",
"    ]. The data were insufficient to analyze differences in cognitive impairment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clinical monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depressive symptoms and cognition should both be monitored. Several depression rating scales are available; the most common is the Hamilton Rating Scale for Depression (HRSD or \"HAM-D\") [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/41\">",
"     41",
"    </a>",
"    ]. The scale should be administered at baseline, weekly during the course of ECT, and when the ECT course is completed.",
"   </p>",
"   <p>",
"    Many scales are also available for monitoring cognition; the most common is the Mini Mental State Examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/42\">",
"     42",
"    </a>",
"    ]. It is easy to use and adequate for routine clinical use, although its sensitivity may be limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/43\">",
"     43",
"    </a>",
"    ]. More comprehensive neuropsychologic testing may be indicated for selected patients (eg, those with known cognitive deficits at baseline). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of cognitive impairment and dementia\", section on 'Mini-Mental State Examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     ADVERSE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adverse effects of ECT may be divided into medical or cognitive effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Adverse medical effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality rate of ECT is 2 to 4 deaths per 100,000 treatments, making it one of the safest procedures performed under general anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. A review of 10 systematic reviews, 7 meta-analyses, and 3 practice guidelines found that the mortality associated with ECT was comparable to the mortality associated with minor procedures involving general anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/27\">",
"     27",
"    </a>",
"    ]. Concerns that ECT causes structural brain damage have been dispelled by multiple human and nonhuman primate studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/1,27\">",
"     1,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mortality is mostly related to cardiopulmonary events. Patients with coronary heart disease may be at risk for cardiac ischemic events because the seizure increases cardiac workload and oxygen demand. The cardiovascular effects of ECT are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=see_link&amp;anchor=H6#H6\">",
"     \"Medical consultation for electroconvulsive therapy\", section on 'Cardiovascular effects'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Other adverse medical effects include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aspiration pneumonia &ndash; Risk is increased in patients who do not have an empty stomach [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fracture &ndash; Patients with severe osteoporosis are at increased risk of fracture, and extra care should be taken to insure excellent muscle relaxation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dental and tongue injuries &ndash; These may occur when the oral bite block is not fully protective [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/47\">",
"       47",
"      </a>",
"      ]. Loose teeth are at risk for dislodgement during the procedure and possible aspiration, and should be stabilized or extracted before ECT.",
"     </li>",
"     <li>",
"      Headache &ndash; This is the most common, nonserious adverse medical effect of ECT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/48-50\">",
"       48-50",
"      </a>",
"      ]. Patients should be told to expect some headache after each treatment. It is typically managed with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"       ibuprofen",
"      </a>",
"      given after the treatment. Prophylaxis with IV",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/62/35808?source=see_link\">",
"       ketorolac",
"      </a>",
"      30 mg may be considered for patients with significant post-ECT headache [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nausea &ndash; Transient, postprocedure nausea is common and is the result of the anesthesia and airway manipulation, which may introduce air into the stomach. Prophylaxis with IV",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/2/21544?source=see_link\">",
"       ondansetron",
"      </a>",
"      4 mg should be given to patients with significant post-ECT nausea.",
"     </li>",
"     <li>",
"      Other somatic symptoms &ndash; Patients may complain of other somatic symptoms such as myalgias. However, one study assessed a group of depressed patients pre-ECT and during an acute course of ECT, and found the frequency of somatic symptoms other than headache did not increase [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/52\">",
"       52",
"      </a>",
"      ]. The authors suggested that these other somatic symptoms may have been due to the depressive illness, the use of psychotropic medications, or withdrawal from such medications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Adverse cognitive effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients report some adverse cognitive effects during and after a course of ECT. The incidence depends upon electrode placement, stimulus type and dose, anesthesia, and the patient's pretreatment cognitive status. A systematic review found four studies in which the proportion of patients who reported any memory loss ranged from 51 to 79 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=see_link&amp;anchor=H6#H6\">",
"     \"Technique for performing electroconvulsive therapy (ECT) in adults\", section on 'Electrode placement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ECT causes three types of cognitive impairment:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute confusion",
"     </li>",
"     <li>",
"      Anterograde amnesia",
"     </li>",
"     <li>",
"      Retrograde amnesia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The acute confusional state is the result of both the seizure and the anesthesia. It typically resolves 10 to 30 minutes after the procedure.",
"   </p>",
"   <p>",
"    Anterograde amnesia is the decreased ability to retain newly acquired information. It occurs during a course of ECT and typically resolves within two weeks after completing the course. We thus suggest that patients refrain from driving for 24 hours after an ECT treatment or from making important business or personal decisions one to two weeks after completing an acute course of ECT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Retrograde amnesia involves forgetting recent memories and is the most anxiety-producing cognitive effect of ECT. The memories are for events that occur during the course of ECT and a period of weeks to a few months prior to that. The deficits are greatest and most persistent for knowledge about public or world events (impersonal memory) compared with knowledge about the self (personal memory) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/55\">",
"     55",
"    </a>",
"    ]. Bilateral ECT causes more retrograde amnesia than right unilateral. Retrograde amnesia recovers more slowly than anterograde amnesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/55-57\">",
"     55-57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some of the lost memories of events prior to the course of ECT may be expected to return, while others may not. A systematic review found four studies in which the proportion of patients who reported persistent or permanent memory loss ranged from 29 to 55 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/53\">",
"     53",
"    </a>",
"    ]. The etiology of these more severe memory impairments is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Regardless, the typical ECT patient is profoundly depressed and accepts some degree of memory loss as a reasonable tradeoff for resolution of the depressive episode.",
"   </p>",
"   <p>",
"    Impaired cognition due to depression often improves after a course of ECT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/60\">",
"     60",
"    </a>",
"    ]. A review of ECT in elderly patients with impaired cognition due to depression (\"pseudodementia\") examined six studies that tested cognition before and after ECT in patients mostly 55 years or older [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/61\">",
"     61",
"    </a>",
"    ]. Patients were assessed with a cognitive screening instrument, either the Mini Mental State Examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/42\">",
"     42",
"    </a>",
"    ] or the Mattis Dementia Rating Scale [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/62\">",
"     62",
"    </a>",
"    ]. Global cognitive functioning in patients with cognitive impairment improved in all studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     CONTINUATION AND MAINTENANCE ECT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuation ECT is the practice of providing a single ECT treatment, at an interval of one to eight weeks, during the first six months after remission. The purpose is to prevent relapse of the mood or psychotic episode that prompted the acute course of ECT. Maintenance ECT refers to ECT given beyond continuation ECT, to patients who have recovered from the acute mood or psychotic episode but require treatment to prevent recurrence of a new episode. Continuation and maintenance ECT are usually outpatient procedures.",
"   </p>",
"   <p>",
"    Mood and psychotic disorders are chronically recurring illnesses. Therefore, continuation and maintenance treatment (with pharmacotherapy, ECT, psychotherapy, or a combination) are required for most patients who recover from an initial episode. As an example, in a prospective, observational study of 154 patients with major depression who remitted after successful treatment with ECT in community hospitals, 64 percent relapsed during 24 weeks of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest continuation and maintenance ECT for depressed patients who have successfully completed a course of acute ECT and:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Relapse without continuation and maintenance treatment (either pharmacotherapy or ECT), and require a second a course of acute ECT",
"     </li>",
"     <li>",
"      Fail one or more courses of continuation and maintenance pharmacotherapy",
"     </li>",
"     <li>",
"      Prefer continuation and maintenance ECT",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The electrode placement used for continuation and maintenance ECT should be the same as that used for acute ECT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=see_link&amp;anchor=H6#H6\">",
"     \"Technique for performing electroconvulsive therapy (ECT) in adults\", section on 'Electrode placement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pharmacotherapy is often combined with continuation and maintenance ECT, with improved outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/64,65\">",
"     64,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The schedule for continuation and maintenance ECT generally starts with weekly treatments for several weeks, and gradually tapers to the maximal interval that allows the patient to remain euthymic. Following an acute course of ECT three times per week, we suggest treatments be administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/38\">",
"     38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Weekly for four weeks",
"     </li>",
"     <li>",
"      Biweekly for eight weeks",
"     </li>",
"     <li>",
"      Monthly for two months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some patients continue to taper down to one treatment every three months, depending upon their clinical status and preference. Patients who benefit from maintenance ECT can receive it indefinitely. Use of self report and clinician administered rating scales to monitor the patient&rsquo;s clinical status is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/40/4745?source=see_link\">",
"     \"Using scales to monitor symptoms and treatment of depression (measurement based care)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18246781\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following acute ECT, continuation ECT alone appears to be comparable to continuation pharmacotherapy alone. A six month, open label randomized trial compared continuation treatment with either ECT or pharmacotherapy in 184 patients who remitted from unipolar major depression after an acute course of bilateral ECT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients were assigned to a fixed schedule of continuation bilateral ECT or combination pharmacotherapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    . In both groups, 46 percent of patients remained euthymic. In addition, the two continuation treatments did not differ in memory effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Continuation and maintenance treatment with ECT plus pharmacotherapy may be more effective than pharmacotherapy alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/64\">",
"     64",
"    </a>",
"    ]. A one year, open label, randomized trial compared maintenance ECT (weekly for six weeks and then every two weeks) plus pharmacotherapy (antidepressants in nearly all patients;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    and antipsychotics were used in varying numbers of patients) with pharmacotherapy alone in 56 patients who responded to an acute course of ECT for unipolar or bipolar major depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/65\">",
"     65",
"    </a>",
"    ]. Relapse occurred in fewer patients who received combination treatment than pharmacotherapy alone (32 versus 61 percent).",
"   </p>",
"   <p>",
"    Cognitive effects of continuation and maintenance ECT are generally minor or nonexistent:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A controlled trial randomly assigned depressed patients who remitted with an acute course of ECT to continuation ECT or continuation pharmacotherapy, and evaluated them with an extensive battery of memory tests at baseline and after 24 weeks of treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/38,66\">",
"       38,66",
"      </a>",
"      ]. Neurocognitive performance was comparable for the two groups.",
"     </li>",
"     <li>",
"      A randomized trial compared maintenance ECT plus pharmacotherapy with pharmacotherapy alone in patients who remitted from major depression after an acute course of ECT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/65\">",
"       65",
"      </a>",
"      ]. Cognitive functioning and subjective memory were comparable the two groups.",
"     </li>",
"     <li>",
"      An observational study evaluated 20 patients (multiple diagnoses) receiving maintenance ECT with a comprehensive neuropsychologic battery and retested them one year later [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/67\">",
"       67",
"      </a>",
"      ]. There were no significant differences in test scores over time. In addition, test scores for the patients receiving maintenance ECT did not differ significantly from a control group of patients not receiving ECT.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     STIGMA, ACCESS, AND TRAINING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Stigma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stigma remains the biggest impediment to the appropriate use of ECT. The level of knowledge about modern ECT among patients and medical practitioners is low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/68\">",
"     68",
"    </a>",
"    ]. The portrayal of ECT in the media as a crude and coercive treatment remains problematic, frightening off patients who might benefit from it. Improved education about ECT among health care professionals will lead to more favorable perceptions about its use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Access",
"    </span>",
"    &nbsp;&mdash;&nbsp;Access to ECT in the United States is variable and very limited in some rural areas. It is rarely available to patients in state psychiatric hospitals. Patients with no or limited insurance coverage may be unable to pay for ECT, leading to a situation in which ECT is preferentially available to more affluent patients with better insurance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Training",
"    </span>",
"    &nbsp;&mdash;&nbsp;ECT is a standard part of training in general psychiatry residency programs in the United States, and many programs offer in-depth hands-on training. Guidelines for curriculum are suggested by the American Psychiatric Association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/29\">",
"     29",
"    </a>",
"    ]. Several post-residency hands-on training courses are offered throughout the United States. These may be identified by contacting the American Psychiatric Association at 888-357-7924.",
"   </p>",
"   <p>",
"    Individual United States hospitals issue privileges to psychiatrists to perform ECT, but there is no board certification for ECT in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/21/41305/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/15/37106?source=see_link\">",
"       \"Patient information: Electroconvulsive therapy (ECT) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/50/37664?source=see_link\">",
"       \"Patient information: Electroconvulsive therapy (ECT) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89471769\">",
"    <span class=\"h1\">",
"     OUTSIDE SOURCES OF PATIENT EDUCATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the requirements for obtaining informed consent for ECT is that patients receive adequate information about the procedure. Additional written material is available for patients and family members to augment discussions with the psychiatrist at",
"    <a class=\"external\" href=\"file://jama.ama-assn.org/cgi/reprint/285/10/1390\">",
"     file://jama.ama-assn.org/cgi/reprint/285/10/1390",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Educational material explaining ECT is also available as part of a document entitled \"Brain Stimulation Therapies\" that is published by the National Institute of Mental Health. This publication can be obtained through a toll-free number, 866-615-6464, or online at the Web site",
"    <a class=\"external\" href=\"file://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml\">",
"     file://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml",
"    </a>",
"    . The Web site also provides information about depression in language intended for the lay public.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indications include severe unipolar depression, bipolar disorder, schizophrenia, schizoaffective disorder, delirium, and neuroleptic malignant syndrome. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41416?source=see_link\">",
"       \"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The pre-ECT evaluation should include a complete medical history emphasizing cardiopulmonary disease and prior surgeries. Appropriate physical examination and laboratory evaluation, guided by the relevant history, should be performed. Medical consultation prior to ECT is indicated for most patients 40 years or older, and is frequently obtained in younger patients as well. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pre-ECT evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inducing a seizure causes transient increases in blood pressure, pulse, and intracranial pressure, which can have deleterious effects. Organ systems of most concern are cardiovascular, pulmonary, and central nervous system. Medication to blunt increases in heart rate and blood pressure is indicated prior to ECT and during the procedure in patients for whom these increases would be detrimental. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Specific medical conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiac complications are the most common cause of serious morbidity and mortality during ECT. Patients with coronary heart disease should be evaluated prior to ECT with a careful cardiac history and ECG. Additional cardiovascular diagnostic testing and evaluation by a cardiology consultant may be indicated for selected patients, and for any patient with unstable disease. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Coronary heart disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Recent myocardial infarction and unstable angina present increased risk. Careful consideration of the",
"      <span class=\"nowrap\">",
"       risk/benefit",
"      </span>",
"      ratio of ECT in such cases is essential. The key factors are the extent of myocardial damage and subsequent healing, and the residual functional cardiac status. In general, the longer one waits after a myocardial infarction, the safer it is to perform ECT. For patients who have had a myocardial infarction and are not at imminent risk from their depressive episode, we suggest waiting a minimum of three months prior to starting a course of ECT. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'History of myocardial infarction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many psychotropic medications may be continued during a course of ECT for their synergistic effect without compromising safety, including antidepressants, antipsychotics, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      . Morning doses on the day of ECT are given after the patient has recovered from that day's procedure. Anticonvulsants and benzodiazepines often interfere with ECT and may need to be tapered and discontinued. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Psychotropic drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most cardiac, antihypertensive, and anti-reflux medications should be taken with a small sip of water approximately two hours before each ECT treatment. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Other drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The psychiatrist should ensure that the consent process conforms to all state and local laws and statutes, and hospital policies. Informed consent requires that the patient receives adequate information about depression and ECT, is capable of understanding and acting reasonably on this information, and is given the opportunity to consent in the absence of coercion. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Informed consent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A typical course of ECT consists of 6 to 12 treatments, individualized for each patient. Treatment should usually continue until remission of mood or psychotic symptoms. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Number of treatments'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Standard practice in the United States is to give ECT three times per week. The routine in many other countries is twice a week. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Treatment frequency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Continuation ECT is the practice of providing a single ECT treatment, at an interval of one to eight weeks, during the first six months after remission. Maintenance ECT refers to ECT given beyond continuation ECT. Continuation and maintenance ECT are usually provided on an outpatient basis to prevent relapse or recurrence of the mood or psychotic episode that prompted the acute course of ECT. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Continuation and maintenance ECT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mortality rate of ECT is 2 to 4 deaths per 100,000 treatments, making it one of the safest procedures performed under general anesthesia. Mortality is mostly related to cardiopulmonary events. Other adverse medical effects include aspiration pneumonia, fracture, dental and tongue injuries, headache, and nausea. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Adverse medical effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients report some adverse cognitive effects during and after a course of ECT, including acute confusion (delirium), anterograde amnesia, and retrograde amnesia. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Adverse cognitive effects'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/1\">",
"      Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med 2007; 357:1939.",
"     </a>",
"    </li>",
"    <li>",
"     Shorter, E, Healy, D. Shock Therapy: A History of Electroconvulsive Treatment in Mental Illness, Rutgers University Press, New Brunswick 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/3\">",
"      Kalinowsky LB. History of convulsive therapy. Ann N Y Acad Sci 1986; 462:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/4\">",
"      Endler NS. The Origins of Electroconvulsive Therapy (ECT). Convuls Ther 1988; 4:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/5\">",
"      Bini, L. Experimental researches on epileptic attacks induced by the electric current. Am J Psychiatry 1938; 94:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/6\">",
"      Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980, and 1986. Am J Psychiatry 1994; 151:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/7\">",
"      Hermann RC, Dorwart RA, Hoover CW, Brody J. Variation in ECT use in the United States. Am J Psychiatry 1995; 152:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/8\">",
"      Rudorfer MV, Risby ED, Hsiao JK, et al. Disparate Biochemical Actions of Electroconvulsive Therapy and Antidepressant Drugs. Convuls Ther 1988; 4:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/9\">",
"      Nikisch G, Math&eacute; AA. CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. Eur Psychiatry 2008; 23:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/10\">",
"      Lapierre YD. Neurotransmitter functions in depression. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/11\">",
"      Math&eacute; AA. Neuropeptides and electroconvulsive treatment. J ECT 1999; 15:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/12\">",
"      Fink M, Nemeroff CB. A Neuroendocrine View of ECT. Convuls Ther 1989; 5:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/13\">",
"      Sackeim HA, Decina P, Prohovnik I, et al. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry 1983; 18:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/14\">",
"      Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ect. Am J Psychiatry 2001; 158:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/15\">",
"      Perrin JS, Merz S, Bennett DM, et al. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci U S A 2012; 109:5464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/16\">",
"      Sackeim HA, Luber B, Katzman GP, et al. The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry 1996; 53:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/17\">",
"      Madsen TM, Treschow A, Bengzon J, et al. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 2000; 47:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/18\">",
"      Lamont SR, Stanwell BJ, Hill R, et al. Ketamine pre-treatment dissociates the effects of electroconvulsive stimulation on mossy fibre sprouting and cellular proliferation in the dentate gyrus. Brain Res 2005; 1053:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/19\">",
"      Bolwig TG, Madsen TM. Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl 2007; :130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/20\">",
"      Piccinni A, Del Debbio A, Medda P, et al. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharmacol 2009; 19:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/21\">",
"      Okamoto T, Yoshimura R, Ikenouchi-Sugita A, et al. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/22\">",
"      Rasmussen KG, Rummans TA, Richardson JW. Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am 2002; 25:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/23\">",
"      Zielinski RJ, Roose SP, Devanand DP, et al. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993; 150:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/24\">",
"      Tess AV, Smetana GW. Medical evaluation of patients undergoing electroconvulsive therapy. N Engl J Med 2009; 360:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/25\">",
"      Magid M, Lapid MI, Sampson SM, Mueller PS. Use of electroconvulsive therapy in a patient 10 days after myocardial infarction. J ECT 2005; 21:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/26\">",
"      Saito S. Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth 2005; 19:142.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Executive Summary: Prepared for the January 27-28, 2011 meeting of the Neurological Devices Panel. Meeting to Discuss the Classification of Electroconvulsive Therapy Devices (ECT). file://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM240933.pdf (Accessed on May 25, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/28\">",
"      Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry 2009; 66:729.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. American Psychiatric Association, Washington, DC 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/30\">",
"      Baghai TC, Marcuse A, Brosch M, et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 2006; 7:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/31\">",
"      Nothdurfter C, Eser D, Sch&uuml;le C, et al. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 2006; 7:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/32\">",
"      Klapheke MM. Combining ECT and Antipsychotic Agents: Benefits and Risks. Convuls Ther 1993; 9:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/33\">",
"      Dolenc TJ, Rasmussen KG. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J ECT 2005; 21:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/34\">",
"      Greenberg RM, Pettinati HM. Benzodiazepines and Electroconvulsive Therapy. Convuls Ther 1993; 9:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/35\">",
"      Sienaert P, Peuskens J. Anticonvulsants during electroconvulsive therapy: review and recommendations. J ECT 2007; 23:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/36\">",
"      Rasmussen KG, Zorumski CF. Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry 1993; 54:427.",
"     </a>",
"    </li>",
"    <li>",
"     Kellner, CH, Pritchett, JT, Beale, MD, Coffey, CE. Handbook of ECT, American Psychiatric Press, Inc., Washington, DC 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/38\">",
"      Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/39\">",
"      Kellner CH, Knapp R, Husain MM, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 2010; 196:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/40\">",
"      Charlson F, Siskind D, Doi SA, et al. ECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules. J Affect Disord 2012; 138:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/41\">",
"      HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/42\">",
"      Folstein MF, Folstein SE, McHugh PR. \"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/43\">",
"      Porter R, Heenan H, Reeves J. Early effects of electroconvulsive therapy on cognitive function. J ECT 2008; 24:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/44\">",
"      Kramer BA. Use of ECT in California, revisited: 1984-1994. J ECT 1999; 15:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/45\">",
"      Abrams R. The mortality rate with ECT. Convuls Ther 1997; 13:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/46\">",
"      Baker NJ. Electroconvulsive Therapy and Severe Osteoporosis: Use of a Nerve Stimulator to Assess Paralysis. Convuls Ther 1986; 2:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/47\">",
"      Minneman SA. A history of oral protection for the ECT patient: past, present, and future. Convuls Ther 1995; 11:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/48\">",
"      Datto CJ. Side effects of electroconvulsive therapy. Depress Anxiety 2000; 12:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/49\">",
"      Devanand DP, Polanco P, Cruz R, et al. The efficacy of ECT in mixed affective states. J ECT 2000; 16:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/50\">",
"      Weiner SJ, Ward TN, Ravaris CL. Headache and electroconvulsive therapy. Headache 1994; 34:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/51\">",
"      Rasmussen KG, Petersen KN, Sticka JL, et al. Correlates of myalgia in electroconvulsive therapy. J ECT 2008; 24:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/52\">",
"      Devanand DP, Fitzsimons L, Prudic J, Sackeim HA. Subjective side effects during electroconvulsive therapy. Convuls Ther 1995; 11:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/53\">",
"      Rose D, Fleischmann P, Wykes T, et al. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ 2003; 326:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/54\">",
"      Fink M, Abrams R, Bailine S, Jaffe R. Ambulatory electroconvulsive therapy: report of a task force of the association for convulsive therapy. Association for Convulsive Therapy . Convuls Ther 1996; 12:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/55\">",
"      Lisanby SH, Maddox JH, Prudic J, et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 2000; 57:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/56\">",
"      Sobin C, Sackeim HA, Prudic J, et al. Predictors of retrograde amnesia following ECT. Am J Psychiatry 1995; 152:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/57\">",
"      McElhiney, MG, Moody, B, Steif, B, et al. Autobiographical memory and mood: Effects of Electroconvulsive therapy. Neuropsychology 1995; 9:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/58\">",
"      Sackeim HA. Memory and ECT: from polarization to reconciliation. J ECT 2000; 16:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/59\">",
"      Kellner CH. Electroconvulsive therapy in a perfect world. J ECT 2007; 23:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/60\">",
"      Stoudemire A, Hill CD, Morris R, Dalton ST. Improvement in depression-related cognitive dysfunction following ECT. J Neuropsychiatry Clin Neurosci 1995; 7:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/61\">",
"      Tielkes CE, Comijs HC, Verwijk E, Stek ML. The effects of ECT on cognitive functioning in the elderly: a review. Int J Geriatr Psychiatry 2008; 23:789.",
"     </a>",
"    </li>",
"    <li>",
"     Mattis, S. Mental status examination for organic mental syndrome in the elderly patient. In: Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians, Bellak, L, Karasu, TB (Ed), Grune &amp; Stratton, New York 1976. pp.77.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/63\">",
"      Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry 2004; 55:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/64\">",
"      Navarro V, Gast&oacute; C, Torres X, et al. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. Am J Geriatr Psychiatry 2008; 16:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/65\">",
"      Nordenskj&ouml;ld A, von Knorring L, Ljung T, et al. Continuation Electroconvulsive Therapy With Pharmacotherapy Versus Pharmacotherapy Alone for Prevention of Relapse of Depression: A Randomized Controlled Trial. J ECT 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/66\">",
"      Smith GE, Rasmussen KG Jr, Cullum CM, et al. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study. J Clin Psychiatry 2010; 71:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/67\">",
"      Rami L, Bernardo M, Boget T, et al. Cognitive status of psychiatric patients under maintenance electroconvulsive therapy: a one-year longitudinal study. J Neuropsychiatry Clin Neurosci 2004; 16:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/68\">",
"      McFarquhar TF, Thompson J. Knowledge and attitudes regarding electroconvulsive therapy among medical students and the general public. J ECT 2008; 24:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/69\">",
"      Payne NA, Prudic J. Electroconvulsive therapy: Part II: a biopsychosocial perspective. J Psychiatr Pract 2009; 15:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/21/41305/abstract/70\">",
"      Olfson M, Marcus S, Sackeim HA, et al. Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry 1998; 155:22.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1709 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-6AD27EA953-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41305=[""].join("\n");
var outline_f40_21_41305=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY OF ECT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PRE-ECT EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SPECIFIC MEDICAL CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - History of myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Heart failure and valvular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pacemakers and implantable defibrillators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Neurologic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CONCURRENT MEDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Psychotropic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INFORMED CONSENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT COURSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Number of treatments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Treatment frequency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clinical monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ADVERSE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Adverse medical effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Adverse cognitive effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      CONTINUATION AND MAINTENANCE ECT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18246781\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      STIGMA, ACCESS, AND TRAINING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Stigma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Access",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Training",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89471769\">",
"      OUTSIDE SOURCES OF PATIENT EDUCATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/1709\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/1709|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/8/15499\" title=\"table 1\">",
"      Indications for ECT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/11/33981\" title=\"table 2\">",
"      Mgmt pre-exist conditions in ECT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/57/9118\" title=\"table 3\">",
"      ECT consent acute phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/22/10606\" title=\"table 4\">",
"      ECT consent continuation rx",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21145?source=related_link\">",
"      Medical consultation for electroconvulsive therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/50/37664?source=related_link\">",
"      Patient information: Electroconvulsive therapy (ECT) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/15/37106?source=related_link\">",
"      Patient information: Electroconvulsive therapy (ECT) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=related_link\">",
"      Preoperative medical evaluation of the healthy patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13128?source=related_link\">",
"      Technique for performing electroconvulsive therapy (ECT) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41416?source=related_link\">",
"      Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/40/4745?source=related_link\">",
"      Using scales to monitor symptoms and treatment of depression (measurement based care)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_21_41306="Psoriasis plaque";
var content_f40_21_41306=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54581%7EDERM%2F78531%7EDERM%2F70962%7EDERM%2F66374%7EDERM%2F53509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54581%7EDERM%2F78531%7EDERM%2F70962%7EDERM%2F66374%7EDERM%2F53509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plaque",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous plaque with coarse scale is present on the knee of this patient with psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-defined erythematous plaque is present in the inframammary area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nail pits in psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous pits are present on the nail of this patient with psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oil drop sign and distal onycholysis in psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Discoloration of the nail plate and distal onycholysis (separation of the nail plate from the nail bed) are present in this patient with psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nail psoriasis with subungual hyperkeratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Marked subungual hyperkeratosis is present on several nails of this patient with psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41306=[""].join("\n");
var outline_f40_21_41306=null;
var title_f40_21_41307="Symptoms of GBM";
var content_f40_21_41307=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F65078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F65078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Initial symptoms in 565 patients with grade III or IV malignant glioma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade III, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade IV, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Headache",
"       </td>",
"       <td>",
"        53",
"       </td>",
"       <td>",
"        57",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seizure",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Memory loss",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motor weakness",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        36",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Visual symptoms",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Language deficit",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        36",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cognitive changes",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Personality changes",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        27",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Change in consciousness",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea and vomiting",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sensory deficit",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Papilledema",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Glioma Outcomes Project, Chang, SM, et al, JAMA 2005; 293:557.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41307=[""].join("\n");
var outline_f40_21_41307=null;
var title_f40_21_41308="Characteristics estab RA";
var content_f40_21_41308=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F51732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F51732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of arthritis in established rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Characteristics",
"       </td>",
"       <td class=\"subtitle1\">",
"        Prominent in RA",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comparison to other forms of arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polyarticular involvement",
"       </td>",
"       <td>",
"        Usually polyarthritis (&ge;5 joints, often with compression tenderness of MCP and MTP joints",
"       </td>",
"       <td>",
"        Peripheral SpA&nbsp;usually with fewer involved joints (but RA can also be oligoarticular at onset)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronicity",
"       </td>",
"       <td>",
"        &ge;6 weeks",
"       </td>",
"       <td>",
"        Viral infectious causes of&nbsp;arthritis&nbsp;are frequently self-limited",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammation",
"       </td>",
"       <td>",
"        <p>",
"         Synovial joint swelling",
"        </p>",
"        <p>",
"         CRP, ESR elevation",
"        </p>",
"       </td>",
"       <td>",
"        OA has more bony swelling, and significantly lower CRP and ESR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symmetry",
"       </td>",
"       <td>",
"        Same joint regions of contralateral extremities",
"       </td>",
"       <td>",
"        Peripheral SpA&nbsp;usually asymmetric",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Upper and lower extremity",
"       </td>",
"       <td>",
"        Small and/or large joints of both upper and lower extremities",
"       </td>",
"       <td>",
"        Peripheral SpA&nbsp;involve mostly lower extremity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erosions",
"       </td>",
"       <td>",
"        Bony destruction seen on imaging",
"       </td>",
"       <td>",
"        Most other forms of arthritis are non-erosive; psoriatic arthritis&nbsp;characterized by&nbsp;both&nbsp;bony proliferative&nbsp;and adjacent destructive (erosive) processes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoantibodies",
"       </td>",
"       <td>",
"        RF, anti-CCP, anti-RA33",
"       </td>",
"       <td>",
"        Most other diseases are \"seronegative\" for these markers (and may be associated with other types of autoantibodies)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recent infections or comorbid conditions associated with arthritides",
"       </td>",
"       <td>",
"        Usually absent&nbsp;",
"       </td>",
"       <td>",
"        Urinary or GI infections (reactive arthritis); psoriasis (psoriatic arthritis); IBD; ankylosing spondylitis; connective tissue diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Genetic markers",
"       </td>",
"       <td>",
"        Particular DR (shared epitope) types",
"       </td>",
"       <td>",
"        Differing genetic markers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Morning stiffness",
"       </td>",
"       <td>",
"        Typically 60 min or more",
"       </td>",
"       <td>",
"        In OA and other inflammatory arthritides stiffness is less frequent and shorter duration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory disease affecting spine",
"       </td>",
"       <td>",
"        &nbsp;Cervical spine, frequently in atlantoaxial region",
"       </td>",
"       <td>",
"        In SpA, inflammatory&nbsp;abnormalities frequent in sacroiliac joints, bony proliferation&nbsp;at vertebral bodies with ossification of intervertebral ligaments is present; clinically manifests as \"inflammatory back pain\"",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     RA: rheumatoid arthritis; MCP: metacarpophalangeal; MTP: metatarsophalagneal; SpA: spondyloarthritis; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; OA: osteoarthritis; RF: rheumatoid factor; anti-CCP: anti-cyclic citrullinated peptide antibodies; DQ and DR: major histocompatibility class II antigens.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Josef Smolen, MD, Daniel Aletaha, MD, and Klaus Machold, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41308=[""].join("\n");
var outline_f40_21_41308=null;
var title_f40_21_41309="Contents: Dermatologic diagnosis";
var content_f40_21_41309=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Dermatologic diagnosis",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Dermatologic diagnosis",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/45/35541\">",
"           Approach to dermatologic diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/28/37318\">",
"           Approach to the patient with a scalp eruption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/54/35688\">",
"           Approach to the patient with annular skin lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/54/14186\">",
"           Approach to the patient with cutaneous blisters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/34/552\">",
"           Approach to the patient with facial erythema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/8/29831\">",
"           Approach to the patient with macular skin lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/48/28423\">",
"           Approach to the patient with pustular skin lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/43/39608\">",
"           Approach to the patient with retiform (angulated) purpura",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/51/31543\">",
"           Dermatologic procedures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/11/13497\">",
"           Dermoscopic evaluation of skin lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/4/13385\">",
"           Erythroderma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/15/4345\">",
"           Evaluation of adults with cutaneous lesions of vasculitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/57/38807\">",
"           Overview of dermoscopy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/15/36090\">",
"           Overview of nail disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/31/28150\">",
"           Patch testing",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-B4BD3E0856-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f40_21_41309=[""].join("\n");
var outline_f40_21_41309=null;
var title_f40_21_41310="Causes of FUO over time";
var content_f40_21_41310=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 613px\">",
"   <div class=\"ttl\">",
"    The percentage of patients with fever of unknown origin by cause during four decades",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 593px; height: 331px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Mourad, O, Palda, V, Detsky, AS. Arch Intern Med 2003; 163:545.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41310=[""].join("\n");
var outline_f40_21_41310=null;
var title_f40_21_41311="Gibbus deformity";
var content_f40_21_41311=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gibbus deformity of the spine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: McKusick, VA. Heritable Disorders of Connective Tissue, 4th ed, Mosby, St Louis 1972. Copyright &copy; 1972 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_21_41311=[""].join("\n");
var outline_f40_21_41311=null;
